Publications published since 2010 from OUS - Department of Haematology

916 publications found

Publications 2024

1. Abdollahi P, Norseth HM, Schjesvold F (2024)
   Advances and challenges in anti-cancer vaccines for multiple myeloma
   Front Immunol, 15, 1411352
   DOI 10.3389/fimmu.2024.1411352, PubMed 39161773
2. Al Hamed R, Labopin M, Wu D, Gedde-Dahl T, Aljurf M, Forcade E, Salmenniemi U, Passweg J, Maertens J, Pabst T, Versluis J, Itäla-Remes M, Huang XJ, Van Gorkom G, Schroeder T, Sanz J, Blaise D, Reményi P, Schanz U, Esteve J, Gorin NC, Ciceri F, Mohty M (2024)
   Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
   Bone Marrow Transplant, 59 (10), 1458-1465
   DOI 10.1038/s41409-024-02373-5, PubMed 39095548
3. Andersen K, Tjønnfjord GE, Ramslien LF, Panagopoulos I (2024)
   RUNX1::MIR99AHG Chimera in Acute Myeloid Leukemia
   Genes Chromosomes Cancer, 63 (9), e23272
   DOI 10.1002/gcc.23272, PubMed 39324493
4. Arrieta-Bolaños E, Bonneville EF, Crivello P, Robin M, Gedde-Dahl T, Salmenniemi U, Kröger N, Yakoub-Agha I, Crawley C, Choi G, Broers AEC, Forcade E, Carre M, Poiré X, Huynh A, Lenhoff S, Ciceri F, Tholouli E, Schroeder T, Deconinck E, Carlson K, de Wreede LC, Hoogenboom JD, Malard F, Ruggeri A et al. (2024)
   Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
   J Clin Oncol, 42 (28), 3287-3299
   DOI 10.1200/JCO.24.00582, PubMed 39167735
5. Arrieta-Bolaños E, van der Burg LLJ, Gedde-Dahl T, Robin M, Salmenniemi U, Kröger N, Yakoub-Agha I, Huynh A, Crawley C, Deconinck E, Bulabois CE, Forcade E, Tholouli E, van der Hem JGK, van Balen P, Hoogenboom JD, de Wreede LC, Malard F, Ruggeri A, Fleischhauer K (2024)
   Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS
   Blood, 144 (16), 1747-1751
   DOI 10.1182/blood.2024024351, PubMed 39102621
6. Askeland FB, Frøen HM, Bolstad N, Thorsby PM, Schjesvold F, Wammer ACP, Følling I, Tjønnfjord GE (2024)
   Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy
   Clin Lymphoma Myeloma Leuk (in press)
   DOI 10.1016/j.clml.2024.10.005, PubMed 39500643
7. Baliakas P, Tesi B, Cammenga J, Stray-Pedersen A, Jahnukainen K, Andersen MK, Ågerstam H, Creignou M, Dybedal I, Raaschou-Jensen K, Grønbæk K, Kilpivaara O, Lindberg EH, Wartiovaara-Kautto U (2024)
   How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
   Hemasphere, 8 (8), e145
   DOI 10.1002/hem3.145, PubMed 39139355
8. Berentsen S, Vos JMI, Malecka A, Tjønnfjord GE, D'Sa S (2024)
   The impact of individual clinical features in cold agglutinin disease: hemolytic versus non-hemolytic symptoms
   Expert Rev Hematol, 17 (8), 479-492
   DOI 10.1080/17474086.2024.2372333, PubMed 38938203
9. Brune M, Kiss T, Anderson H, Nicklasson M, Delage R, Finke J, Gedde-Dahl T, Hébert J, Höglund M, Kaare A, Lazarevic V, Möllgård L, Remes K, Ritchie D, Spyridonidis A, Sabloff M, Spearing R, Wallhult E, Ljungman P (2024)
   Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients
   Bone Marrow Transplant (in press)
   DOI 10.1038/s41409-024-02408-x, PubMed 39223244
10. Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes LTN, Vålerhaugen H, Heim S, Micci F (2024)
    NUP214 fusion genes in acute leukemias: genetic characterization of rare cases
    Front Oncol, 14, 1371980
    DOI 10.3389/fonc.2024.1371980, PubMed 38571499
11. Brunetti M, Andersen K, Trøen G, Micci F, Spetalen S, Lenartova A, Tandsæther MR, Panagopoulos I (2024)
    Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10)
    Front Oncol, 14, 1428984
    DOI 10.3389/fonc.2024.1428984, PubMed 39391249
12. Chalandon Y, Eikema DJ, Moiseev I, Ciceri F, Koster L, Vydra J, Passweg J, Rovira M, Ozcelik T, Gedde-Dahl T, Kröger N, Potter V, Yakoub-Agha I, Rambaldi A, Itälä-Remes M, Tanase A, Onida F, Gurnari C, Scheid C, Drozd-Sokolowska J, Raj K, McLornan DP, Robin M (2024)
    Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms
    Blood Adv, 8 (18), 4792-4802
    DOI 10.1182/bloodadvances.2024013468, PubMed 39008719
13. Christiansen CF, Risbo N, Ghanima W, Linder M, Bahmanyar S, Seesaghur A, Clouser M, Nørgaard M, Sørensen HT (2024)
    Platelet response to romiplostim amongst patients with newly diagnosed, persistent, and chronic immune thrombocytopenia in routine clinical practice in Denmark, Sweden, and Norway
    Br J Haematol, 205 (4), 1497-1507
    DOI 10.1111/bjh.19688, PubMed 39102877
14. Cimini LA, Luijten D, Barco S, Ghanima W, Jervan Ø, Kahn SR, Konstantinides S, Lachant D, Nakano Y, Ninaber M, van Es J, van Mens T, Vonk Noordegraaf A, Becattini C, Klok FA (2024)
    Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis
    ERJ Open Res, 10 (4)
    DOI 10.1183/23120541.01010-2023, PubMed 39076522
15. Dam M, Centanni M, Friberg LE, Centanni D, Karlsson MO, Stensig Lynggaard L, Johannsdottir IM, Wik HS, Malmros J, Vaitkeviciene GE, Griskevicius L, Hallböök H, Jónsson ÓG, Overgaard U, Schmiegelow K, Hansen SN, Heyman M, Albertsen BK (2024)
    Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia
    Leukemia, 38 (4), 712-719
    DOI 10.1038/s41375-024-02153-6, PubMed 38287133
16. Domingos V, Nezvalova-Henriksen K, Dadkhah A, Moreno-Martinez ME, Ben Hassine K, Pires V, Kröger N, Bauters T, Hassan M, Duncan N, Kalwak K, Ansari M, Langebrake C, Admiraal R (2024)
    A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)
    Bone Marrow Transplant (in press)
    DOI 10.1038/s41409-024-02413-0, PubMed 39271948
17. Drozd-Sokolowska J, Gras L, Koster L, Martino R, Salas MQ, Salmenniemi U, Zudaire T, Yañez L, Bellido M, Collin M, Kaufmann M, Kozlowski P, Poiré X, Ferra C, Sampol A, Wilson KMO, Cairoli A, Gedde-Dahl T, Deconinck E, Mirabile M, Suarez F, Raj K, Van Gelder M, Yakoub-Agha I, Tournilhac O et al. (2024)
    Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
    Haematologica, 109 (5), 1608-1613
    DOI 10.3324/haematol.2023.284359, PubMed 38205539
18. Enden T (2024)
    Have a pretty radiant day!
    Tidsskr Nor Laegeforen, 144 (2)
    DOI 10.4045/tidsskr.24.0049, PubMed 38349095
19. Enden T (2024)
    [Not Available]
    Tidsskr Nor Laegeforen, 144
    DOI 10.4045/tidsskr.24.0110, PubMed 38506168
20. Enden T (2024)
    On the dating market
    Tidsskr Nor Laegeforen, 144 (7)
    DOI 10.4045/tidsskr.24.0286, PubMed 38832600
21. Fageräng B, Cyranka L, Schjalm C, McAdam KE, Larsen CS, Heinzelbecker J, Gedde-Dahl T, Würzner R, Espevik T, Tjønnfjord GE, Garred P, Barratt-Due A, Tvedt THA, Mollnes TE (2024)
    The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation
    Front Immunol, 15, 1422370
    DOI 10.3389/fimmu.2024.1422370, PubMed 38938578
22. Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
    Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
    Leukemia, 38 (4), 781-787
    DOI 10.1038/s41375-024-02145-6, PubMed 38278960
23. Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
    Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
    Leukemia, 38 (4), 925
    DOI 10.1038/s41375-024-02184-z, PubMed 38418611
24. Giebel S, Labopin M, Peric Z, Passweg J, Blaise D, Salmenniemi U, Beauvais D, Reményi P, Chevallier P, Mielke S, Gedde-Dahl T, Cornelissen JJ, Balsat M, Bug G, Bazarbachi A, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
    Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT
    Transplant Cell Ther (in press)
    DOI 10.1016/j.jtct.2024.07.016, PubMed 39069077
25. Gjærde LK, Brück O, Gagelmann N, Gavriilaki E, Inngjerdingen M, Keranen M, Kisch A, Myhre AE, Olivieri A, Perez-Simon JA, Perovic D, Perovic V, Piekarska A, Pulanic D, Rathje K, Van Veen S, Dachy G, Moiseev I, Penack O, Peric Z, Greinix H, Lee SJ, Wolff D, Schoemans H (2024)
    Standardized translations of the Lee Chronic GvHD Symptom Scale to 12 European languages: an EU COST Action cGvHD Eurograft project
    Bone Marrow Transplant, 59 (10), 1477-1479
    DOI 10.1038/s41409-024-02374-4, PubMed 39020019
26. Grdinic AG, Radovanovic S, Gleditsch J, Jørgensen CT, Asady E, Pettersen HH, Delibasic B, Ghanima W (2024)
    Developing a machine learning model for bleeding prediction in patients with cancer-associated thrombosis receiving anticoagulation therapy
    J Thromb Haemost, 22 (4), 1094-1104
    DOI 10.1016/j.jtha.2023.12.034, PubMed 38184201
27. Grønvold BL, Ali MM, Myklebust TÅ, Lenartova A, Remberger M, Abrahamsen IW, Tjønnfjord GE, Myhre AE, Fløisand Y, Gedde-Dahl T (2024)
    Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
    EJHaem, 5 (1), 117-124
    DOI 10.1002/jha2.842, PubMed 38406518
28. Guièze R, Eikema DJ, Koster L, Schetelig J, Sengeloev H, Passweg J, Finke J, Arat M, Broers AEC, Stölzel F, Byrne J, Castilla-Llorente C, Dreger P, Eder M, Gedde-Dahl T, Kröger N, Ribera Santasusana JM, Richardson D, Rambaldi A, Yañez L, Van Gelder M, Drozd-Sokolowska J, Raj K, Yakoub-Agha I, Tournilhac O et al. (2024)
    Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
    Bone Marrow Transplant, 59 (7), 950-956
    DOI 10.1038/s41409-024-02256-9, PubMed 38503942
29. Halvorsen B, Viermyr HK, Ueland T, Sagen EL, Michelsen AE, Bjerkeli V, Nor-Solidarity Study Group, Tveita AA, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Trøseid M, Dahl TB, Aukrust P, Gregersen I (2024)
    IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement
    J Infect, 89 (1), 106176
    DOI 10.1016/j.jinf.2024.106176, PubMed 38719108
30. Hamnvik LHD, Eide-Olsen S, Fosseng A, Schjesvold FH (2024)
    Estimated Financial Savings From Clinical Studies at Oslo Myeloma Center in the Period 2015-2021
    Clin Lymphoma Myeloma Leuk (in press)
    DOI 10.1016/j.clml.2024.07.015, PubMed 39191633
31. Hamnvik LHD, Tjønnfjord GE, Spetalen S, Dalgaard J (2024)
    Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case report
    J Med Case Rep, 18 (1), 245
    DOI 10.1186/s13256-024-04562-8, PubMed 38736000
32. Harrison SP, Baumgarten SF, Chollet ME, Stavik B, Bhattacharya A, Almaas R, Sullivan GJ (2024)
    Parenteral nutrition emulsion inhibits CYP3A4 in an iPSC derived liver organoids testing platform
    J Pediatr Gastroenterol Nutr, 78 (5), 1047-1058
    DOI 10.1002/jpn3.12195, PubMed 38529852
33. Haukeland-Parker S, Jervan Ø, Ghanima W, Spruit MA, Holst R, Tavoly M, Gleditsch J, Johannessen HH (2024)
    Physical activity following pulmonary embolism and clinical correlates in selected patients: a cross-sectional study
    Res Pract Thromb Haemost, 8 (2), 102366
    DOI 10.1016/j.rpth.2024.102366, PubMed 38562511
34. Holland P, Istre M, Ali MM, Gedde-Dahl T, Buechner J, Wildhagen M, Brunvoll SH, Horvath S, Matsuyama S, Dahl JA, Stölzel F, Søraas A (2024)
    Epigenetic aging of human blood cells is influenced by the age of the host body
    Aging Cell, 23 (5), e14112
    DOI 10.1111/acel.14112, PubMed 38439206
35. Holm S, Michelsen AE, Schultz NH, Ueland T, Reikvam H, Holme PA, Aukrust P, Halvorsen B (2024)
    Human papilloma virus vaccine induced thrombocytopenia accompanied by a wide spectrum of reversible inflammatory responses - a case report
    Scand J Clin Lab Invest, 84 (6), 425-427
    DOI 10.1080/00365513.2024.2400663, PubMed 39264796
36. Holme PA, Blatný J, Chowdary P, Lassila R, O'Connell N, Hermans C, Álvarez Román MT, Négrier C, Coppola A, Oldenburg J (2024)
    Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A
    Haemophilia, 30 (5), 1109-1114
    DOI 10.1111/hae.15031, PubMed 38986684
37. Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R (2024)
    Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study
    Haemophilia, 30 (2), 388-394
    DOI 10.1111/hae.14930, PubMed 38229269
38. Imbery JF, Wiik C, Heinzelbecker J, Jebsen JK, Dobbing MK, Bottini N, Stanford SM, Munthe LA, Tjønnfjord GE, Tveita A, Szodoray P, Nakken B (2024)
    CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity
    Mol Ther Oncol, 32 (3), 200841
    DOI 10.1016/j.omton.2024.200841, PubMed 39474602
39. Kakwangire P, Atukunda P, Ngari M, Westerberg AC, Iversen PO, Muhoozi G (2024)
    Long-term effects on depressive symptoms among Ugandan mothers - Findings from a follow-up of a cluster-randomized education trial in a rural low-resource setting
    J Affect Disord, 351, 598-606
    DOI 10.1016/j.jad.2024.01.263, PubMed 38307132
40. Kakwangire P, Muhoozi G, Ngari M, Matovu N, Westerberg AC, Iversen PO, Atukunda P (2024)
    8-Year Follow-up of a Maternal Education Trial in a Low-Resource Setting
    Pediatrics, 153 (4)
    DOI 10.1542/peds.2023-063352, PubMed 38505933
41. Kardel KR, Iversen PO, Kaaya AN, Muhoozi G, Veierød MB, Wangen KR, Børøsund E, Friberg PA (2024)
    A pragmatic randomized trial to examine the effect of combining healthy diet with mindfulness cognitive therapy to reduce depressive symptoms among university students in a low-resource setting: protocol for the NutriMind Project
    BMC Psychiatry, 24 (1), 610
    DOI 10.1186/s12888-024-06056-9, PubMed 39261786
42. Kleftogiannnis D, Gavasso S, Tislevoll BS, van der Meer N, Motzfeldt IKF, Hellesøy M, Gullaksen SE, Griessinger E, Fagerholt O, Lenartova A, Fløisand Y, Schuringa JJ, Gjertsen BT, Jonassen I (2024)
    Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry
    iScience, 27 (7), 110261
    DOI 10.1016/j.isci.2024.110261, PubMed 39021803
43. Koroma AS, Stephenson KB, Iversen PO, Manary MJ, Hendrixson DT (2024)
    The Effect of Breastfeeding Practices of Undernourished Mothers in Rural Sierra Leone on Infant Growth and Mortality
    Children (Basel), 11 (2)
    DOI 10.3390/children11020233, PubMed 38397345
44. Lin Y, Qiu L, Usmani S, Joo CW, Costa L, Derman B, Du J, Einsele H, Fernandez de Larrea C, Hajek R, Ho PJ, Kastritis E, Martinez-Lopez J, Mateos MV, Mikhael J, Moreau P, Nagarajan C, Nooka A, O'Dwyer M, Schjesvold F, Sidana S, van de Donk NW, Weisel K, Zweegman S, Raje N et al. (2024)
    Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
    Lancet Oncol, 25 (8), e374-e387
    DOI 10.1016/S1470-2045(24)00094-9, PubMed 38821074
45. Loke J, Labopin M, Craddock C, Socié G, Gedde-Dahl T, Blaise D, Forcade E, Salmenniemi U, Huynh A, Versluis J, Yakoub-Agha I, Labussière-Wallet H, Maertens J, Passweg J, Bulabois CE, Gabellier L, Mielke S, Castilla-Llorente C, Deconinck E, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
    Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study
    Cancer, 130 (15), 2642-2651
    DOI 10.1002/cncr.35308, PubMed 38581695
46. Lund T, Gundesen MT, Juul Vangsted A, Helleberg C, Haukås E, Silkjær T, Asmussen JT, Manuela Teodorescu E, Amdi Jensen B, Schmidt Slørdahl T, Nahi H, Waage A, Abildgaard N, Schjesvold F, Nordic Myeloma Study Group (2024)
    In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
    Blood Cancer J, 14 (1), 65
    DOI 10.1038/s41408-024-01046-2, PubMed 38622134
47. Małecka A, Østlie I, Trøen G, Małecki J, Delabie J, Tierens A, Munthe LA, Berentsen S, Tjønnfjord GE (2024)
    Gene expression analysis revealed downregulation of complement receptor 1 in clonal B cells in cold agglutinin disease
    Clin Exp Immunol, 216 (1), 45-54
    DOI 10.1093/cei/uxad135, PubMed 38133636
48. McDonald GB, Landsverk OJB, McGovern DPB, Aasebø A, Paulsen V, Haritunians T, Reims HM, McLaughlin BM, Zisman T, Li D, Elholm ETMM, Jahnsen FL, Georges GE, Gedde-Dahl T (2024)
    Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease
    Heliyon, 10 (1), e24026
    DOI 10.1016/j.heliyon.2024.e24026, PubMed 38283244
49. Mohty R, Bazarbachi AH, Labopin M, Esteve J, Kröger N, Cornelissen JJ, Blaise D, Socié G, Maury S, Ganser A, Gedde-Dahl T, von dem Borne P, Bourhis JH, Bulabois CE, Yakoub-Agha I, Pabst C, Nguyen S, Chevallier P, Huynh A, Bazarbachi A, Nagler A, Ciceri F, Mohty M (2024)
    Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT
    Bone Marrow Transplant, 59 (11), 1534-1541
    DOI 10.1038/s41409-024-02384-2, PubMed 39143183
50. Montoro J, Eikema DJ, Tuffnell J, Potter V, Kalwak K, Halkes CJM, Kulagin A, Collin M, Wynn RF, Robinson S, Nicholson E, Sengeloev H, Clay J, Halahleh K, Skorobogatova E, Sanz J, Passweg J, Mielke S, Ryhänen S, Carpenter B, Gedde-Dahl T, Tholouli E, Fanin R, Lewalle P, Kulasekararaj A et al. (2024)
    Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
    Blood, 144 (3), 323-333
    DOI 10.1182/blood.2024024173, PubMed 38643511
51. Moukalled N, Labopin M, Versluis J, Socié G, Blaise D, Salmenniemi U, Rambaldi A, Gedde-Dahl T, Tholouli E, Kröger N, Bourhis JH, Von Dem Borne P, Daguindau E, Forcade E, Nagler A, Esteve J, Ciceri F, Bazarbachi A, Mohty M (2024)
    Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
    Am J Hematol, 99 (3), 360-369
    DOI 10.1002/ajh.27187, PubMed 38165072
52. Nagler A, Labopin M, Swoboda R, Schroeder T, Hamladji RM, Griskevicius L, Salmenniemi U, Rambaldi A, Mielke S, Kulagin A, Passweg J, Luft T, Gedde-Dahl T, Forcade E, Helbig G, Stelljes M, Castilla-Llorente C, Spyridonidis A, Brissot E, Ciceri F, Mohty M (2024)
    Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Bone Marrow Transplant, 59 (7), 1012-1021
    DOI 10.1038/s41409-024-02284-5, PubMed 38615143
53. Nagler A, Ngoya M, Galimard JE, Labopin M, Blau IW, Kröger N, Gedde-Dahl T, Schroeder T, Burns D, Salmenniemi U, Rambaldi A, Choi G, Peffault de Latour R, Vydra J, Sengeloev H, Eder M, Mielke S, Forcade E, Kulagin A, Ciceri F, Mohty M (2024)
    Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Am J Hematol, 99 (9), 1732-1745
    DOI 10.1002/ajh.27383, PubMed 38856236
54. Ngari M, Mwangome M, Ouma N, Nyaguara A, Mturi N, Obiero C, Kamau A, Walson JL, Iversen PO, Maitland K, Snow RW, Berkley J (2024)
    Inpatient and postdischarge mortality among children with anaemia and malaria parasitaemia in Kenya: a cohort study
    BMJ Glob Health, 9 (10)
    DOI 10.1136/bmjgh-2024-016600, PubMed 39433400
55. Nielsen LK, Schjesvold F, Möller S, Guldbrandsen N, Hansson M, Remes K, Peceliunas V, Abildgaard N, Gregersen H, King MT (2024)
    Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group
    J Patient Rep Outcomes, 8 (1), 15
    DOI 10.1186/s41687-024-00691-2, PubMed 38315268
56. Nørgaard JN, Moore KLF, Slørdahl TS, Vik A, Tvedt THA, Schjesvold F (2024)
    VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
    Blood Cancer J, 14 (1), 60
    DOI 10.1038/s41408-024-01047-1, PubMed 38594252
57. Oldenburg J, Hay C, Peyvandi F, Tagliaferri A, Holme PA, Álvarez-Román MT, Biron-Andréani C, Malmström H, Bystrická L, Lethagen S, A‐SURE Study Group (2024)
    Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE Study
    Eur J Haematol (in press)
    DOI 10.1111/ejh.14309, PubMed 39434416
58. Panagopoulos I, Andersen K, Stavseth V, Torkildsen S, Heim S, Tandsæther MR (2024)
    Germline MYOF1::WNK4 and VPS25::MYOF1 Chimeras Generated by the Constitutional Translocation t(17;19)(q21;p13) in Two Siblings With Myelodysplastic Syndrome
    Cancer Genomics Proteomics, 21 (3), 272-284
    DOI 10.21873/cgp.20446, PubMed 38670586
59. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR (2024)
    Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome
    Anticancer Res, 44 (4), 1389-1397
    DOI 10.21873/anticanres.16935, PubMed 38537997
60. Partanen A, Waage A, Peceliunas V, Schjesvold F, Anttila P, Säily M, Uttervall K, Putkonen M, Carlson K, Haukas E, Sankelo M, Szatkowski D, Hansson M, Marttila A, Svensson R, Axelsson P, Lauri B, Mikkola M, Karlsson C, Abelsson J, Ahlstrand E, Sikiö A, Klimkowska M, Matuzeviciene R, Fenstad MH et al. (2024)
    Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
    Cancers (Basel), 16 (5)
    DOI 10.3390/cancers16051024, PubMed 38473382
61. Patrick-Brown TDJH, Barratt-Due A, Trøseid M, Dyrhol-Riise AM, Nezvalova-Henriksen K, Kåsine T, Aukrust P, Olsen IC, NOR Solidarity consortium (2024)
    The effects of remdesivir on long-term symptoms in patients hospitalised for COVID-19: a pre-specified exploratory analysis
    Commun Med (Lond), 4 (1), 231
    DOI 10.1038/s43856-024-00650-4, PubMed 39533001
62. Pawlyn C, Schjesvold FH, Cairns DA, Wei LJ, Davies F, Nadeem O, Abdulhaq H, Mateos MV, Laubach J, Weisel K, Ludwig H, Rajkumar SV, Sonneveld P, Jackson G, Morgan G, Richardson PG (2024)
    Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
    Blood Cancer J, 14 (1), 134
    DOI 10.1038/s41408-024-01109-4, PubMed 39134544
63. Penack O, Abouqateb M, Peczynski C, Boreland W, Gülbas Z, Gedde-Dahl T, Castilla-Llorente C, Kröger N, Eder M, Rambaldi A, Bonifazi F, Blau IW, Stelljes M, Dreger P, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
    PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
    Blood Cancer J, 14 (1), 45
    DOI 10.1038/s41408-024-01032-8, PubMed 38485723
64. Penack O, Abouqateb M, Peczynski C, Boreland W, Kröger N, Stelljes M, Gedde-Dahl T, Blau IW, Schroeder T, Salmenniemi U, Kulagin A, Peffault de Latour R, Mielke S, Zeiser R, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
    ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
    Leukemia, 38 (5), 1156-1163
    DOI 10.1038/s41375-024-02225-7, PubMed 38538862
65. Podgorica M, Drivet E, Viken JK, Richman A, Vestbøstad J, Szodoray P, Kvam AK, Wik HS, Tjønnfjord GE, Munthe LA, Frietze S, Schjerven H (2024)
    Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
    Eur J Haematol, 112 (5), 731-742
    DOI 10.1111/ejh.14164, PubMed 38192186
66. Pour L, Szarejko M, Bila J, Schjesvold FH, Spicka I, Maisnar V, Jurczyszyn A, Grudeva-Popova Z, Hájek R, Usenko G, Thuresson M, Norin S, Jarefors S, Bakker NA, Richardson PG, Mateos MV (2024)
    Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
    Haematologica, 109 (3), 895-905
    DOI 10.3324/haematol.2023.283509, PubMed 37646660
67. Qvigstad C, Sørensen LQ, Tjønnfjord GE, Holme PA, Age-related DeVelopments ANd ComorbiditiEs in hemophilia Working Group (2024)
    The association between unemployment and treatment among adults with hemophilia
    Res Pract Thromb Haemost, 8 (5), 102514
    DOI 10.1016/j.rpth.2024.102514, PubMed 39188890
68. Reding MT, Lalezari S, Kenet G, Di Minno G, Ducore J, Solms A, Shah A, Holme PA, Poulsen LH, Meijer K, Simpson M, Mancuso ME (2024)
    Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review
    Drugs R D, 24 (3), 359-381
    DOI 10.1007/s40268-024-00481-7, PubMed 39162954
69. Reding MT, Simpson M, Ducore J, Holme PA, Maas Enriquez M, Mancuso ME (2024)
    Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12-<18 Years at Enrolment into PROTECT VIII
    Acta Haematol, 1-10 (in press)
    DOI 10.1159/000538702, PubMed 38599195
70. Richardson PG, Perrot A, Miguel JS, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang SY, Minarik J, Cavo M, Prince HM, Macé S, Zhang R, Dubin F, Morisse MC, Anderson KC (2024)
    Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
    Haematologica, 109 (7), 2239-2249
    DOI 10.3324/haematol.2023.284325, PubMed 38299578
71. Rodriguez-Otero P, Usmani S, Cohen AD, van de Donk NWCJ, Leleu X, Gállego Pérez-Larraya J, Manier S, Nooka AK, Mateos MV, Einsele H, Minnema M, Cavo M, Derman BA, Puig N, Gay F, Ho PJ, Chng WJ, Kastritis E, Gahrton G, Weisel K, Nagarajan C, Schjesvold F, Mikhael J, Costa L, Raje NS et al. (2024)
    International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
    Lancet Oncol, 25 (5), e205-e216
    DOI 10.1016/S1470-2045(24)00043-3, PubMed 38697166
72. Rogn Å, Jensen JL, Iversen PO, Singh PB (2024)
    Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
    Sci Rep, 14 (1), 3455
    DOI 10.1038/s41598-024-53919-y, PubMed 38342941
73. Rogn Å, Jensen JL, Iversen PO, Singh PB (2024)
    Publisher Correction: Post-COVID-19 patients suffer from chemosensory, trigeminal, and salivary dysfunctions
    Sci Rep, 14 (1), 9213
    DOI 10.1038/s41598-024-59915-6, PubMed 38649502
74. Røed-Undlien H, Schultz NH, Amundsen EK, Wollmann BM, Molden E, Akerkar RR, Bjørnstad JL (2024)
    Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC-MS and anti-Xa assay?
    Int J Lab Hematol, 46 (5), 946-952
    DOI 10.1111/ijlh.14311, PubMed 38808488
75. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2024)
    Corrigendum to < IN-VITRO APIXABAN REMOVAL BY CYTOSORB® WHOLE BLOOD ADSORBER. AN EXPERIMENTAL STUDY.> <[Journal of Cardiothoracic and Vascular Anesthesia 36/6 (2024) 1636 - 1644]>
    J Cardiothorac Vasc Anesth, 38 (7), 1606-1607
    DOI 10.1053/j.jvca.2024.03.039, PubMed 38580477
76. Røra M, Solberg MS, Moore KLF, Slørdahl TS (2024)
    Incidence and prevention of skeletal-related events in multiple myeloma patients: A population-based real-world experience
    EJHaem, 5 (4), 669-676
    DOI 10.1002/jha2.928, PubMed 39157600
77. Rørvik SD, Torkildsen S, Bruserud Ø, Tvedt THA (2024)
    Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification
    Ann Hematol, 103 (4), 1103-1119
    DOI 10.1007/s00277-024-05680-5, PubMed 38443661
78. Scheid C, Eikema DJ, van Gelder M, Salmenniemi U, Maertens J, Passweg J, Blaise D, Byrne JL, Kröger N, Sockel K, Chevallier P, Bourhis JH, Cornelissen JJ, Sengeloev H, Finke J, Snowden JA, Gedde-Dahl T, Cornillon J, Schanz U, Patel A, Koster L, de Wreede LC, Hayden P, Raj K, Drozd-Sokolowska J et al. (2024)
    Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
    Blood, 144 (4), 445-456
    DOI 10.1182/blood.2023022273, PubMed 38728380
79. Schjesvold FH, Ludwig H, Delimpasi S, Robak P, Coriu D, Tomczak W, Pour L, Spicka I, Dimopoulos MA, Masszi T, Chernova NG, Sandberg A, Thuresson M, Norin S, Bakker NA, Mateos MV, Richardson PG, Sonneveld P (2024)
    Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
    Haematologica, 109 (7), 2331-2336
    DOI 10.3324/haematol.2023.284635, PubMed 38426292
80. Sefland Ø, Gullaksen SE, Omsland M, Reikvam H, Galteland E, Tran HTT, Spetalen S, Singh SK, Van Zeeburg HJT, Van De Loosdrecht AA, Gjertsen BT (2024)
    Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease
    Cytometry B Clin Cytom (in press)
    DOI 10.1002/cyto.b.22197, PubMed 39078053
81. Sletten M, Skogstrøm KB, Lind SM, Tinholt M, Stavik B, Rayner S, Iversen N (2024)
    Elevated TFPI is a prognostic factor in hepatocellular carcinoma: Putative role of miR-7-5p and miR-1236-3p
    Thromb Res, 241, 109073
    DOI 10.1016/j.thromres.2024.109073, PubMed 38945092
82. Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, van de Donk NWCJ, Katodritou E, Schjesvold F, Balari AS, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A et al. (2024)
    A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
    Future Oncol, 1-21 (in press)
    DOI 10.1080/14796694.2024.2394323, PubMed 39287147
83. Stevanovic S, Dalmao-Fernandez A, Mohamed D, Nyman TA, Kostovski E, Iversen PO, Savikj M, Nikolic N, Rustan AC, Thoresen GH, Kase ET (2024)
    Time-dependent reduction in oxidative capacity among cultured myotubes from spinal cord injured individuals
    Acta Physiol (Oxf), 240 (7), e14156
    DOI 10.1111/apha.14156, PubMed 38711362
84. Styczynski J, Tridello G, Knelange N, Wendel L, Ljungman P, Mikulska M, Gil L, Cesaro S, Averbuch D, von dem Borne P, Xhaard A, Mielke S, Neven B, Snowden JA, Dalle JH, Rubio MT, Crawley C, Maertens J, Kuball J, Chevallier P, Michel G, Gabriel M, Burns D, Wynn RF, Renard C et al. (2024)
    Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
    Bone Marrow Transplant, 59 (10), 1402-1412
    DOI 10.1038/s41409-024-02361-9, PubMed 38987308
85. Tinholt M, Tekpli X, Torland LA, Tahiri A, Geisler J, Kristensen V, Sandset PM, Iversen N (2024)
    The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy
    J Thromb Haemost, 22 (5), 1319-1335
    DOI 10.1016/j.jtha.2024.01.003, PubMed 38237862
86. Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Olsnes Kittang A, Werlenius O, Lorentz F, Rasmussen B, Cammenga J, Weber D, Lindholm C, Wiggh J, Dimitriou M, Moen AE, Yip Lundström L, von Bahr L, Baltzer-Sollander K, Jädersten M, Kytölä S, Walldin G, Ljungman P et al. (2024)
    Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation
    J Clin Oncol, 42 (12), 1378-1390
    DOI 10.1200/JCO.23.01159, PubMed 38232336
87. van der Maas NG, Versluis J, Nasserinejad K, van Rosmalen J, Pabst T, Maertens J, Breems D, Manz M, Cloos J, Ossenkoppele GJ, Floisand Y, Gradowska P, Löwenberg B, Huls G, Postmus D, Pignatti F, Cornelissen JJ (2024)
    Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
    Blood Cancer J, 14 (1), 56
    DOI 10.1038/s41408-024-01037-3, PubMed 38538587
88. Vethe NT, Andersen AM, Gedde-Dahl T, Büchner J, Bergan S (2024)
    Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor
    Ther Drug Monit, 46 (3), 416-417
    DOI 10.1097/FTD.0000000000001209, PubMed 38648662
89. Viermyr HK, Halvorsen B, Sagen EL, Michelsen AE, Barrat-Due A, Kåsine T, Nezvalova-Henriksen K, Dyrhol-Riise AM, Nor‐Solidarity Consortium, Lerum TV, Müller F, Tonby K, Tveita A, Aukrust P, Trøseid M, Ueland T, Dahl TB (2024)
    High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial
    J Intern Med, 296 (3), 249-259
    DOI 10.1111/joim.13820, PubMed 39011800
90. Wang HL, Siow R, Schmauck-Medina T, Zhang J, Sandset PM, Filshie C, Lund Ø, Partridge L, Bergersen LH, Juel Rasmussen L, Palikaras K, Sotiropoulos I, Storm-Mathisen J, Rubinsztein DC, Spillantini MG, De Zeeuw CI, Watne LO, Vyhnalek M, Veverova K, Liang KX, Tavernarakis N, Bohr VA, Yokote K, Saarela J, Nilsen H et al. (2024)
    Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: Recent Progress on the Mechanisms and Interventional Strategies
    J Gerontol A Biol Sci Med Sci, 79 (4)
    DOI 10.1093/gerona/glae029, PubMed 38289789
91. Wang J, Sufar EK, Bernhoft A, Seal C, Rempelos L, Hasanaliyeva G, Zhao B, Iversen PO, Baranski M, Volakakis N, Leifert C (2024)
    Mycotoxin contamination in organic and conventional cereal grain and products: A systematic literature review and meta-analysis
    Compr Rev Food Sci Food Saf, 23 (3), e13363
    DOI 10.1111/1541-4337.13363, PubMed 38720588
92. Westerberg NS, Atneosen-Åsegg M, Melheim M, Chollet ME, Harrison SP, Siller R, Sullivan GJ, Almaas R (2024)
    Effect of hypoxia on aquaporins and hepatobiliary transport systems in human hepatic cells
    Pediatr Res (in press)
    DOI 10.1038/s41390-024-03368-0, PubMed 38951656
93. Ye Y, Labopin M, Chen J, Wu D, Gedde-Dahl T, Blaise D, Socie G, Forcade E, Salmenniemi U, Maury S, Versluis J, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Shi J, Ciceri F, Huang H, Mohty M, Gorin NC (2024)
    Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT
    Blood Cancer J, 14 (1), 85
    DOI 10.1038/s41408-024-01072-0, PubMed 38802349
94. Ye Y, Labopin M, Gérard S, Yakoub-Agha I, Blau IW, Aljurf M, Forcade E, Gedde-Dahl T, Burns D, Vydra J, Halahleh K, Hamladji RM, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Zhao Y, Ciceri F, Huang H, Mohty M, Gorin NC (2024)
    Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Am J Hematol, 99 (7), 1290-1299
    DOI 10.1002/ajh.27342, PubMed 38654658
95. Zaboras Z, Jørgensen CT, Stensvold A, Pettersen HH, Grdinic AG, Brækkan SK, Ghanima W, Tavoly M (2024)
    Real-world Data on Treatment Patterns and Bleeding in Cancer-associated Thrombosis: Data from the TROLL Registry
    TH Open, 8 (1), e132-e140
    DOI 10.1055/s-0044-1782219, PubMed 38532938
96. Aarstad HH, Moe SEE, Lybak S, Bruserud Ø, Tvedt THA, Aarstad HJ (2024)
    Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival
    Cancers (Basel), 16 (8)
    DOI 10.3390/cancers16081484, PubMed 38672565

Publications 2023

1. Ahmed M, Muhoozi GKM, Atukunda P, Westerberg AC, Iversen PO, Wangen KR (2023)
   Cognitive development among children in a low-income setting: Cost-effectiveness analysis of a maternal nutrition education intervention in rural Uganda
   PLoS One, 18 (8), e0290379
   DOI 10.1371/journal.pone.0290379, PubMed 37594989
2. Al Hamed R, Ngoya M, Galimard JE, Sengeloev H, Gedde-Dahl T, Kulagin A, Platzbecker U, Yakoub-Agha I, Byrne JL, Valerius T, Socie G, Kröger N, Blaise D, Bazarbachi A, Sanz J, Ciceri F, Nagler A, Mohty M (2023)
   Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study
   Cancer, 129 (17), 2645-2654
   DOI 10.1002/cncr.34843, PubMed 37269074
3. Ali MM, Gedde-Dahl T, Osnes LT, Perrier F, Veierød MB, Tjønnfjord GE, Iversen PO (2023)
   Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial
   Transplant Cell Ther, 29 (6), 364.e1-364.e11
   DOI 10.1016/j.jtct.2023.02.023, PubMed 36878428
4. Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM (2023)
   Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling
   Cell Rep Methods, 3 (12), 100654
   DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095
5. Arnold DM, Clerici B, Ilicheva E, Ghanima W (2023)
   Refractory immune thrombocytopenia in adults: Towards a new definition
   Br J Haematol, 203 (1), 23-27
   DOI 10.1111/bjh.19075, PubMed 37642211
6. Arvanitakis A, Holme PA, Berntorp E, Astermark J (2023)
   Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
   Haemophilia, 29 (4), 1032-1038
   DOI 10.1111/hae.14806, PubMed 37252898
7. Astermark J, Baghaei F, Strandberg K, Toplican PG, Birkedal MF, Grahn EE, Hansson C, Kampmann P, Lehtinen AE, Täckström K, Holme PA, Magnusson M (2023)
   Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
   Ther Adv Hematol, 14, 20406207231202306
   DOI 10.1177/20406207231202306, PubMed 37859645
8. Ayuda-Durán P, Hermansen JU, Giliberto M, Yin Y, Hanes R, Gordon S, Kuusanmäki H, Brodersen AM, Andersen AN, Taskén K, Wennerberg K, Enserink JM, Skånland SS (2023)
   Standardized assays to monitor drug sensitivity in hematologic cancers
   Cell Death Discov, 9 (1), 435
   DOI 10.1038/s41420-023-01722-5, PubMed 38040674
9. Bach-Gansmo T, Hodt A, Schjesvold FH, Gude E, Wien TN (2023)
   Bone scintigraphy reduces the need for biopsy in suspected cardiac amyloidosis
   Tidsskr Nor Laegeforen, 143 (9)
   DOI 10.4045/tidsskr.22.0644, PubMed 37341415
10. Bazarbachi A, Labopin M, Gedde-Dahl T, Remenyi P, Forcade E, Kröger N, Socié G, Craddock C, Bourhis JH, Versluis J, Yakoub-Agha I, Salmenniemi U, El-Cheikh J, Bug G, Esteve J, Nagler A, Ciceri F, Mohty M (2023)
    Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party
    Clin Cancer Res, 29 (21), 4441-4448
    DOI 10.1158/1078-0432.CCR-23-0954, PubMed 37603683
11. Cooper N, Ghanima W, Vianelli N, Valcárcel D, Yavaşoğlu İ, Melikyan A, Ruiz EY, Haenig J, Somenzi O, Lee J, Clark J, Zhang Y, Zaja F (2023)
    Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial
    Am J Hematol, 99 (1), 57-67
    DOI 10.1002/ajh.27131, PubMed 38014779
12. Danielsen AS, Franconeri L, Page S, Myhre AE, Tornes RA, Kacelnik O, Bjørnholt JV (2023)
    Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
    BMC Infect Dis, 23 (1), 247
    DOI 10.1186/s12879-023-08182-3, PubMed 37072711
13. Dusingizimana T, Ramilan T, Weber JL, Iversen PO, Mugabowindekwe M, Ahishakiye J, Brough L (2023)
    Predictors for achieving adequate antenatal care visits during pregnancy: a cross-sectional study in rural Northwest Rwanda
    BMC Pregnancy Childbirth, 23 (1), 69
    DOI 10.1186/s12884-023-05384-0, PubMed 36703102
14. Enden T (2023)
    In training or at work?
    Tidsskr Nor Laegeforen, 143 (2)
    DOI 10.4045/tidsskr.23.0031, PubMed 36718885
15. Enden T (2023)
    Equality under the Health Research Act
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.23.0386, PubMed 37341395
16. Enden T (2023)
    Peer reviewers, commonship and ownership
    Tidsskr Nor Laegeforen, 143 (17)
    DOI 10.4045/tidsskr.23.0751, PubMed 37987061
17. Enden T (2023)
    [Not Available]
    Tidsskr Nor Laegeforen, 143
    DOI 10.4045/tidsskr.23.0843, PubMed 38372223
18. Ettingshausen CE, Hermans C, Holme PA, Cid AR, Khair K, Oldenburg J, Négrier C, Botha J, Lelli A, Windyga J (2023)
    Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study
    Ther Adv Hematol, 14, 20406207231184323
    DOI 10.1177/20406207231184323, PubMed 37529276
19. Fagerhol MK, Schultz NH, Mirlashari MR, Wiedmann MKH, Nissen-Meyer LSH, Søraas AVL, Hetland G (2023)
    DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV-19 vaccination and in normal unvaccinated blood donors
    Scand J Immunol, 98 (1), e13274
    DOI 10.1111/sji.13274, PubMed 37676118
20. Federico L, Tvedt THA, Gainullin M, Osen JR, Chaban V, Lund KP, Tietze L, Tran TT, Lund-Johansen F, Kared H, Lind A, Vaage JT, Stratford R, Tennøe S, Malone B, Clancy T, Myhre AEL, Gedde-Dahl T, Munthe LA (2023)
    Robust spike-specific CD4⁺ and CD8⁺ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
    Front Immunol, 14, 1210899
    DOI 10.3389/fimmu.2023.1210899, PubMed 37503339
21. Fløisand Y, Remberger M, Bigalke I, Josefsen D, Vålerhaugen H, Inderberg EM, Olaussen RW, Gjertsen BT, Goedkoop R, Geiger C, Prinz PU, Schnorfeil FM, Pinkernell K, Schendel DJ, Kvalheim G (2023)
    WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy
    Leukemia, 37 (9), 1842-1849
    DOI 10.1038/s41375-023-01980-3, PubMed 37507426
22. Geelen IGP, Gullaksen SE, Ilander MM, Olssen-Strömberg U, Mustjoki S, Richter J, Blijlevens NMA, Smit WM, Gjertsen BT, Gedde-Dahl T, Markevärn B, Koppes MMA, Westerweel PE, Hjorth-Hansen H, Janssen JJWM (2023)
    Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
    Ann Hematol, 102 (6), 1395-1408
    DOI 10.1007/s00277-023-05199-1, PubMed 37119314
23. Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, Yoshizato T, Rustad EH, Nielsen MM, Bollineni RC, Tran TT, Delic-Sarac M, Gjerdingen TJ, Douvlataniotis K, Laos M, Ali M, Hillen A, Mazzi S, Chin DWL, Mehta A, Holm JS, Bentzen AK, Bill M, Griffioen M, Gedde-Dahl T et al. (2023)
    A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
    Nat Cancer, 4 (10), 1474-1490
    DOI 10.1038/s43018-023-00642-8, PubMed 37783807
24. Gjærde LK, Ruutu T, Peczynski C, Boreland W, Kröger N, Blaise D, Schroeder T, Peffault de Latour R, Gedde-Dahl T, Kulagin A, Sengeløv H, Yakoub-Agha I, Finke J, Eder M, Basak G, Moiseev I, Schoemans H, Koenecke C, Penack O, Perić Z (2023)
    The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party
    Bone Marrow Transplant, 59 (2), 255-263
    DOI 10.1038/s41409-023-02154-6, PubMed 38062242
25. Gleditsch J, Jervan Ø, Klok F, Holst R, Hopp E, Tavoly M, Ghanima W (2023)
    Does the clot burden as assessed by the Mean Bilateral Proximal Extension of the Clot score reflect mortality and adverse outcome after pulmonary embolism?
    Acta Radiol Open, 12 (6), 20584601231187094
    DOI 10.1177/20584601231187094, PubMed 37426515
26. Gotlib J, Castells M, Elberink HO, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, Tashi T, Bulai Livideanu C, Sabato V, Heaney M, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schwartz L, Ward BR, Schafhausen P, Vadas P et al. (2023)
    Avapritinib versus Placebo in Indolent Systemic Mastocytosis
    NEJM Evid, 2 (6), EVIDoa2200339
    DOI 10.1056/EVIDoa2200339, PubMed 38320129
27. Groen K, Schjesvold FH, van der Holt B, Levin MD, Seefat MR, Hansson M, Leys MBL, Regelink JC, Waage A, Szatkowski D, Axelsson P, Hieu Do T, Svirskaite A, van der Spek E, Haukas E, Knut-Bojanowska D, Ypma PF, Blimark CH, Mellqvist UH, van de Donk NWCJ, Sonneveld P, Klostergaard A, Vangsted AJ, Abildgaard N, Zweegman S (2023)
    Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13
    Hemasphere, 7 (9), e940
    DOI 10.1097/HS9.0000000000000940, PubMed 37663673
28. Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO (2023)
    The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
    Ann Hematol, 102 (4), 927-935
    DOI 10.1007/s00277-023-05149-x, PubMed 36864210
29. Gundesen MT, Asmussen JT, Schjesvold F, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Teodorescu EM, Jensen BA, Slørdahl TS, Nahi H, Waage A, Abildgaard N, Lund T, Nordic Myeloma Study Group (2023)
    Potential value of pre-planned imaging of bone disease in multiple myeloma
    Blood Cancer J, 13 (1), 105
    DOI 10.1038/s41408-023-00880-0, PubMed 37419876
30. Harrison SP, Siller R, Tanaka Y, Chollet ME, de la Morena-Barrio ME, Xiang Y, Patterson B, Andersen E, Bravo-Pérez C, Kempf H, Åsrud KS, Lunov O, Dejneka A, Mowinckel MC, Stavik B, Sandset PM, Melum E, Baumgarten S, Bonanini F, Kurek D, Mathapati S, Almaas R, Sharma K, Wilson SR, Skottvoll FS et al. (2023)
    Scalable production of tissue-like vascularized liver organoids from human PSCs
    Exp Mol Med, 55 (9), 2005-2024
    DOI 10.1038/s12276-023-01074-1, PubMed 37653039
31. Hasanaliyeva G, Sufar EK, Wang J, Rempelos L, Volakakis N, Iversen PO, Leifert C (2023)
    Effects of Agricultural Intensification on Mediterranean Diets: A Narrative Review
    Foods, 12 (20)
    DOI 10.3390/foods12203779, PubMed 37893672
32. Hermans C, Astermark J, Carvalho M, Dolan G, d'Oiron R, Fontana P, Holme PA, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Nunez R, Katsarou O, Pabinger-Fasching I, Quintavalle G, Rodgers R, van der Valk P, Windyga J, Jimenez Yuste V, Preložnik Zupan I (2023)
    Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe
    Haemophilia, 29 (3), 913-916
    DOI 10.1111/hae.14761, PubMed 36802089
33. Hermansen JU, Yin Y, Urban A, Myklebust CV, Karlsen L, Melvold K, Tveita AA, Taskén K, Munthe LA, Tjønnfjord GE, Skånland SS (2023)
    A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
    Cell Death Discov, 9 (1), 125
    DOI 10.1038/s41420-023-01426-w, PubMed 37055391
34. Hernández-Boluda JC, Eikema DJ, Koster L, Kröger N, Robin M, de Witte M, Finke J, Finazzi MC, Broers A, Raida L, Schaap N, Chiusolo P, Verbeek M, Hazenberg CLE, Halaburda K, Kulagin A, Labussière-Wallet H, Gedde-Dahl T, Rabitsch W, Raj K, Drozd-Sokolowska J, Battipaglia G, Polverelli N, Czerw T, Yakoub-Agha I et al. (2023)
    Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
    Bone Marrow Transplant, 58 (12), 1357-1367
    DOI 10.1038/s41409-023-02094-1, PubMed 37679647
35. Hillarp A, Holme PA, Wåland EP, Le MS, Henriksson CE, Tjønnfjord GE, Måseide RJ (2023)
    Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
    J Thromb Haemost, 21 (10), 2771-2775
    DOI 10.1016/j.jtha.2023.07.019, PubMed 37543216
36. Iversen PO, Fogelholm M (2023)
    Fluid and water balance: a scoping review for the Nordic Nutrition Recommendations 2023
    Food Nutr Res, 67
    DOI 10.29219/fnr.v67.9975, PubMed 38084150
37. Jervan Ø, Dhayyat A, Gleditsch J, Haukeland-Parker S, Tavoly M, Klok FA, Rashid D, Stavem K, Ghanima W, Steine K (2023)
    Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
    Thromb Res, 229, 7-14
    DOI 10.1016/j.thromres.2023.06.004, PubMed 37356172
38. Jervan Ø, Haukeland-Parker S, Gleditsch J, Tavoly M, Klok FA, Steine K, Johannessen HH, Spruit MA, Atar D, Holst R, Astrup Dahm AE, Sirnes PA, Stavem K, Ghanima W (2023)
    The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
    Chest, 164 (4), 981-991
    DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
39. Jørgensen CT, Brækkan SK, Førsund E, Pettersen HH, Tjønnfjord E, Ghanima W, Tavoly M (2023)
    Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    J Thromb Haemost, 22 (2), 526-533
    DOI 10.1016/j.jtha.2023.10.017, PubMed 37913911
40. Jørgensen CT, Tavoly M, Førsund E, Pettersen HH, Tjønnfjord E, Ghanima W, Brækkan SK (2023)
    Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital
    J Thromb Haemost, 21 (10), 2824-2832
    DOI 10.1016/j.jtha.2023.06.028, PubMed 37394122
41. Jørgensen OJ, Steineger JE, Hillarp A, Pareli Wåland E, Holme PA, Heimdal K, Dheyauldeen S (2023)
    Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
    Laryngoscope Investig Otolaryngol, 9 (1), e1196
    DOI 10.1002/lio2.1196, PubMed 38362186
42. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Andre Holme P, Lassila R, Nummi V, Ranta S, Gretenkort Andersson N, Berntorp E, Astermark J (2023)
    No difference in quality of life between persons with severe haemophilia A and B
    Haemophilia, 29 (4), 987-996
    DOI 10.1111/hae.14759, PubMed 36791275
43. Kisali EP, Iversen PO, Makani J, Sickle Cell Programme, MUHAS (2023)
    Low vitamin B₁₂ blood levels in sickle cell disease: Data from a large cohort study in Tanzania
    Br J Haematol, 204 (3), 1047-1053
    DOI 10.1111/bjh.19265, PubMed 38087805
44. Kreyberg I, Schrumpf E, Fredrik von Krogh C, Lilleng R, Tjønnfjord GE (2023)
    Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
    JAAD Case Rep, 41, 33-36
    DOI 10.1016/j.jdcr.2023.08.036, PubMed 37842157
45. Kristoffersen I, Holte K, Antonsen LP, Ho APT, Kvenshagen LN, Løgavlen VV, Murugaiah P, Tjønnfjord E, Værnesbranden MR (2023)
    A pregnant woman in her thirties with abdominal pain, seizures and haemorrhagic shock
    Tidsskr Nor Laegeforen, 143 (5)
    DOI 10.4045/tidsskr.22.0282, PubMed 36987892
46. Kverneland M, Nakken KO, Hofoss D, Skogan AH, Iversen PO, Selmer KK, Lossius MI (2023)
    Health-related quality of life in adults with drug-resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial
    Epilepsia, 64 (5), e69-e74
    DOI 10.1111/epi.17585, PubMed 36923995
47. Köhn-Luque A, Myklebust EM, Tadele DS, Giliberto M, Schmiester L, Noory J, Harivel E, Arsenteva P, Mumenthaler SM, Schjesvold F, Taskén K, Enserink JM, Leder K, Frigessi A, Foo J (2023)
    Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data
    Cell Rep Methods, 3 (3), 100417
    DOI 10.1016/j.crmeth.2023.100417, PubMed 37056380
48. Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
    Arterial events in cancer patients treated with apixaban for venous thrombosis
    Thromb Res, 228, 128-133
    DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
49. Ludwig H, Terpos E, van de Donk N, Mateos MV, Moreau P, Dimopoulos MA, Delforge M, Rodriguez-Otero P, San-Miguel J, Yong K, Gay F, Einsele H, Mina R, Caers J, Driessen C, Musto P, Zweegman S, Engelhardt M, Cook G, Weisel K, Broijl A, Beksac M, Bila J, Schjesvold F, Cavo M et al. (2023)
    Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
    Lancet Oncol, 24 (6), e255-e269
    DOI 10.1016/S1470-2045(23)00159-6, PubMed 37269857
50. Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
    Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers
    Haemophilia, 29 (2), 658-667
    DOI 10.1111/hae.14752, PubMed 36723510
51. Matlary RED, Grydeland M, Glosli H, Rueegg CS, Holme PA (2023)
    Factors associated with physical activity in young people with haemophilia A on prophylaxis
    Haemophilia, 29 (3), 900-909
    DOI 10.1111/hae.14776, PubMed 36913380
52. Meshkovska B, Gebremariam MK, Atukunda P, Iversen PO, Wandel M, Lien N (2023)
    Barriers and facilitators to implementation of nutrition-related actions in school settings in low- and middle-income countries (LMICs): a qualitative systematic review using the Consolidated Framework for Implementation Research (CFIR)
    Implement Sci Commun, 4 (1), 73
    DOI 10.1186/s43058-023-00454-y, PubMed 37370179
53. Molteberg E, Thorsby PM, Kverneland M, Iversen PO, Selmer KK, Hofoss D, Nakken KO, Taubøll E (2023)
    Stress biomarkers in adult patients with drug-resistant epilepsy on a modified Atkins diet: A prospective study
    Epilepsia Open, 8 (4), 1331-1339
    DOI 10.1002/epi4.12808, PubMed 37574592
54. Moore KLF, Turesson I, Genell A, Klausen TW, Knut-Bojanowska D, Redder L, Sverrisdottir I, Thorsen J, Vangsted AJ, Blimark CH (2023)
    Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden
    Haematologica, 108 (6), 1640-1651
    DOI 10.3324/haematol.2021.280424, PubMed 36300775
55. Myklebust-Hansen HJ, Hasvik E, Solyga VM, Ghanima W (2023)
    The feasibility of self-performing measurements of peripheral oxygen saturation and respiratory exercises in home-isolated COVID-19 patients-a single-arm prospective trial
    Pilot Feasibility Stud, 9 (1), 195
    DOI 10.1186/s40814-023-01415-x, PubMed 38042811
56. Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA (2023)
    Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
    Haemophilia, 30 (1), 98-105
    DOI 10.1111/hae.14899, PubMed 37983883
57. Nagler A, Labopin M, Kröger N, Schroeder T, Gedde-Dahl T, Eder M, Franke GN, Blau IW, Salmenniemi U, Socie G, Schetelig J, Stelljes M, Ciceri F, Mohty M (2023)
    The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
    Bone Marrow Transplant, 58 (12), 1339-1347
    DOI 10.1038/s41409-023-02095-0, PubMed 37660157
58. Nagler A, Labopin M, Mielke S, Passweg J, Blaise D, Gedde-Dahl T, Cornelissen JJ, Salmenniemi U, Yakoub-Agha I, Reményi P, Socié G, van Gorkom G, Labussière-Wallet H, Huang XJ, Rubio MT, Byrne J, Craddock C, Griškevičius L, Ciceri F, Mohty M (2023)
    Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
    Bone Marrow Transplant, 58 (7), 791-800
    DOI 10.1038/s41409-023-01980-y, PubMed 37045942
59. Nahalomo A, Iversen PO, Andreassen BA, Kaaya A, Rukooko AB, Rukundo PM (2023)
    Food insecurity, dietary diversity and the right to adequate food among households in landslide-prone communities in Eastern Uganda: A cohort study
    PLoS One, 18 (4), e0283078
    DOI 10.1371/journal.pone.0283078, PubMed 37053147
60. Nezvalova-Henriksen K, Langebrake C, Bauters T, Moreno-Martinez ME, Ahnfelt E, Ekelund H, Domingos V, Pires V, Bonnin A, Bojanić I, Cabrerizo Y, Terwel S, Tam A (2023)
    Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
    Bone Marrow Transplant, 58 (10), 1069-1074
    DOI 10.1038/s41409-023-02072-7, PubMed 37528237
61. Nyquist OE, Dalgaard J, Spetalen S, Torkildsen S, Frøen H, Galteland E, Klungsøyr O, Bergrem A, Vo C, Sørbø H, Eiken B, Lerdal H, Solvang AK, Jensvoll H, Pandzic T, Baliakas P, Dybedal I (2023)
    Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML
    Br J Haematol, 204 (2), 724-729
    DOI 10.1111/bjh.19226, PubMed 38016923
62. Nørgaard JN, Abildgaard N, Lysén A, Tsykunova G, Vangsted AJ, João C, Remen N, Nielsen LK, Osnes L, Stokke C, Connelly JP, Revheim MR, Nordic Myeloma Study Group (NMSG), Schjesvold F (2023)
    Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation
    Leukemia, 37 (10), 2107-2114
    DOI 10.1038/s41375-023-01998-7, PubMed 37568010
63. Oriol A, Dimopoulos M, Schjesvold F, Beksac M, Facon T, Dhanasiri S, Guo S, Mu Y, Hong K, Gentili C, Galli M, Yagci M, Larocca A, Richardson P, Weisel K (2023)
    Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
    Clin Lymphoma Myeloma Leuk, 24 (3), 165-176.e4
    DOI 10.1016/j.clml.2023.10.009, PubMed 38072743
64. Panagopoulos I, Andersen K, Wik HS, Tandsæther MR, Micci F, Heim S (2023)
    Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of HNRNPH1 With MLLT10
    Cancer Genomics Proteomics, 20 (4), 354-362
    DOI 10.21873/cgp.20387, PubMed 37400142
65. Pedersen S, Kverneland M, Rudi K, Gervin K, Landmark CJ, Iversen PO, Selmer KK (2023)
    Decreased serum concentrations of antiseizure medications in children with drug resistant epilepsy following treatment with ketogenic diet
    Epilepsia Open, 8 (3), 858-866
    DOI 10.1002/epi4.12746, PubMed 37057954
66. Plesner T, Harrison SJ, Quach H, Lee C, Bryant A, Vangsted A, Estell J, Delforge M, Offner F, Twomey P, Choeurng V, Li J, Hendricks R, Ruppert SM, Sumiyoshi T, Miller K, Cho E, Schjesvold F (2023)
    Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma
    Clin Hematol Int, 5 (1), 43-51
    DOI 10.1007/s44228-022-00023-5, PubMed 36656461
67. Poiré X, Labopin M, Polge E, Ganser A, Socié G, Gedde-Dahl T, Forcade E, Finke J, Chalandon Y, Bulabois CE, Yakoub-Agha I, Aljurf M, Kröger N, Blau IW, Nagler A, Esteve J, Mohty M (2023)
    Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype
    Bone Marrow Transplant, 59 (2), 264-269
    DOI 10.1038/s41409-023-02167-1, PubMed 38092959
68. Pradier M, Rodger MA, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Delluc A (2023)
    Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study
    Thromb Haemost, 123 (7), 692-699
    DOI 10.1055/a-2039-3388, PubMed 36809776
69. Reding MT, Pabinger I, Holme PA, Maas Enriquez M, Mancuso ME, Lalezari S, Miesbach W, Di Minno G, Klamroth R, Hermans C (2023)
    Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study
    Ther Adv Hematol, 14, 20406207231166779
    DOI 10.1177/20406207231166779, PubMed 37113811
70. Rempelos L, Wang J, Sufar EK, Almuayrifi MSB, Knutt D, Leifert H, Leifert A, Wilkinson A, Shotton P, Hasanaliyeva G, Bilsborrow P, Wilcockson S, Volakakis N, Markellou E, Zhao B, Jones S, Iversen PO, Leifert C (2023)
    Breeding Bread-Making Wheat Varieties for Organic Farming Systems: The Need to Target Productivity, Robustness, Resource Use Efficiency and Grain Quality Traits
    Foods, 12 (6)
    DOI 10.3390/foods12061209, PubMed 36981136
71. Rinde FB, Jørgensen CT, Pettersen HH, Hansen JB, Ghanima W, Braekkan SK (2023)
    Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
    J Thromb Haemost, 21 (7), 1861-1868
    DOI 10.1016/j.jtha.2023.03.026, PubMed 37004791
72. Robin C, Cordonnier C, Tridello G, Knelange N, Xhaard A, Chantepie S, Tanguy-Schmidt A, Schouten HC, Yeshurun M, Rocha V, Srour M, Kröger N, Ledoux MP, Dalgaard J, Thiebaut A, Giardino S, Calore E, Zuckerman T, Groll AH, Raida L, Avcin S, Vicent MG, Kaare A, Drozd-Sokolowska J, Turlure P et al. (2023)
    Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
    Transplant Cell Ther, 30 (2), 235.e1-235.e10
    DOI 10.1016/j.jtct.2023.11.017, PubMed 38007092
73. Roman G, Stavik B, Lauritzen KH, Sandset PM, Harrison SP, Sullivan GJ, Chollet ME (2023)
    "iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives"
    Front Physiol, 14, 1094249
    DOI 10.3389/fphys.2023.1094249, PubMed 36711019
74. Ruggeri A, De Wreede LC, Müller CR, Crivello P, Bonneville EF, Petersdorf EW, Socié G, Dubois V, Niittyvuopio R, Peräsaari J, Yakoub-Agha I, Cornelissen JJ, Wieten L, Gedde-Dahl T, Forcade E, Crawley CR, Marsh SGE, Gandemer V, Tholouli E, Bulabois CE, Huynh A, Choi G, Deconinck E, Itäla-Remes M, Lenhoff S et al. (2023)
    Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
    Haematologica, 108 (2), 645-652
    DOI 10.3324/haematol.2021.280055, PubMed 35546480
75. Rørvik SD, Abrahamsen IW, Myhre AE, Vo CD, Ødegaard EM, Bruserud Ø, Gedde-Dahl T, Tvedt THA (2023)
    [Chronic graft-versus-host disease]
    Tidsskr Nor Laegeforen, 143 (4)
    DOI 10.4045/tidsskr.22.0525, PubMed 36919292
76. Raab MS, Cohen YC, Schjesvold F, Aardalen K, Oka A, Spencer A, Wermke M, Souza AD, Kaufman JL, Cafro AM, Ocio EM, Doki N, Henson K, Trabucco G, Carrion A, Bender FC, Juif PE, Fessehatsion A, Fan L, Stonehouse JP, Blankenship JW, Granda B, De Vita S, Lu H (2023)
    Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
    Leukemia, 37 (6), 1349-1360
    DOI 10.1038/s41375-023-01883-3, PubMed 37024520
77. Raab MS, Zamagni E, Manier S, Rodriguez-Otero P, Schjesvold F, Broijl A (2023)
    Difficult-to-treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
    EJHaem, 4 (4), 1117-1131
    DOI 10.1002/jha2.743, PubMed 38024633
78. Sanz J, Labopin M, Pabst T, Versluis J, Van Gorkom G, Meijer E, Gedde-Dahl T, Montoro J, Arcese W, Pérez-Simón JA, Schaap N, Maertens J, Vrhovac R, Lanza F, Gorin NC, Mohty M, Ciceri F (2023)
    Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
    Bone Marrow Transplant, 58 (11), 1197-1202
    DOI 10.1038/s41409-023-02075-4, PubMed 37553468
79. Schjesvold FH, Ludwig H, Mateos MV, Larocca A, Abdulhaq H, Norin S, Thuresson M, Bakker NA, Richardson PG, Sonneveld P (2023)
    Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study
    Eur J Haematol, 112 (3), 402-411
    DOI 10.1111/ejh.14127, PubMed 37968873
80. Schultz NH, Bechensteen AG, Tjønnfjord EB, Akkök ÇA, Berg MH (2023)
    New interest group for red blood cell disorders
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.22.0731, PubMed 36811425
81. Shapiro AD, Nakar C, Parker JM, Thibaudeau K, Crea R, Sandset PM (2023)
    Plasminogen, human-tvmh for the treatment of children and adults with plasminogen deficiency type 1
    Haemophilia, 29 (6), 1556-1564
    DOI 10.1111/hae.14849, PubMed 37674358
82. Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosiñol L, Delforge M, Roeloffzen W, Silzle T et al. (2023)
    Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    N Engl J Med, 390 (4), 301-313
    DOI 10.1056/NEJMoa2312054, PubMed 38084760
83. Sonneveld P, Richardson PG, Ludwig H, Dimopoulos MA, Schjesvold FH, Hájek R, Abdulhaq H, Thuresson M, Norin S, Bakker NA, Mateos MV (2023)
    Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
    Clin Lymphoma Myeloma Leuk, 23 (9), 687-696
    DOI 10.1016/j.clml.2023.05.004, PubMed 37355418
84. Spyridonidis A, Labopin M, Gedde-Dahl T, Ganser A, Stelljes M, Craddock C, Wagner-Drouet EM, Versluis J, Schroeder T, Blau IW, Wulf GG, Dreger P, Olesen G, Sengeloev H, Kröger N, Potter V, Forcade E, Passweg J, de Latour RP, Maertens J, Wilson KMO, Bourhis JH, Finke J, Brissot E, Bazarbachi A et al. (2023)
    Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
    Bone Marrow Transplant, 59 (2), 217-223
    DOI 10.1038/s41409-023-02139-5, PubMed 37978322
85. Terpos E, Musto P, Engelhardt M, Delforge M, Cook G, Gay F, van de Donk NWCJ, Ntanasis-Stathopoulos I, Vangsted AJ, Driessen C, Schjesvold F, Cerchione C, Zweegman S, Hajek R, Moreau P, Einsele H, San-Miguel J, Boccadoro M, Dimopoulos MA, Sonneveld P, Ludwig H (2023)
    Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
    Leukemia, 37 (6), 1175-1185
    DOI 10.1038/s41375-023-01920-1, PubMed 37142661
86. Tholin B, Ghanima W, Selle ML, Stavem K (2023)
    Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID-19
    J Intern Med, 294 (6), 721-729
    DOI 10.1111/joim.13706, PubMed 37518983
87. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 115
    DOI 10.1038/s41467-022-35624-4, PubMed 36611026
88. Tislevoll BS, Hellesøy M, Fagerholt OHE, Gullaksen SE, Srivastava A, Birkeland E, Kleftogiannis D, Ayuda-Durán P, Piechaczyk L, Tadele DS, Skavland J, Baliakas P, Hovland R, Andresen V, Seternes OM, Tvedt THA, Aghaeepour N, Gavasso S, Porkka K, Jonassen I, Fløisand Y, Enserink J, Blaser N, Gjertsen BT (2023)
    Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia
    Nat Commun, 14 (1), 1767
    DOI 10.1038/s41467-023-37488-8, PubMed 36997540
89. Tjønnfjord SKV, Ali MM, Tjønnfjord GE (2023)
    Chronic neutropenia in adults
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.22.0491, PubMed 37341406
90. Troensegaard H, Khoury J, Westerberg AC, Tonstad S, Roeters van Lennep J, Veierød MB, Iversen PO, Holven KB, Retterstøl K (2023)
    Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease
    Front Pediatr, 11, 1256815
    DOI 10.3389/fped.2023.1256815, PubMed 37920793
91. Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
    Crit Care, 27 (1), 9
    DOI 10.1186/s13054-022-04205-8, PubMed 36627655
92. Tsykunova G, Kristensen E, Stray-Pedersen A, Bruserud Ø, Sørensen IW, Bruserud Ø, Tvedt THA (2023)
    Adult presentation of ornithine transcarbamylase deficiency: a possible cause of hyperammonemia after high-dose chemotherapy and stem cell transplantation
    Hematology, 28 (1), 2265187
    DOI 10.1080/16078454.2023.2265187, PubMed 38078487
93. Ueland T, Michelsen AE, Tveita AA, Kåsine T, Dahl TB, Finbråten AK, Holten AR, Skjønsberg OH, Mathiessen A, Henriksen KN, Trøseid M, Aaløkken TM, Halvorsen B, Dyrhol-Riise AM, Barratt-Due A, Aukrust P (2023)
    Coagulopathy and adverse outcomes in hospitalized patients with COVID-19: results from the NOR-Solidarity trial
    Res Pract Thromb Haemost, 8 (1), 102289
    DOI 10.1016/j.rpth.2023.102289, PubMed 38292350
94. van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M et al. (2023)
    Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
    Lancet Oncol, 24 (10), 1119-1133
    DOI 10.1016/S1470-2045(23)00405-9, PubMed 37717583
95. Vinnes EW, Lillemoen PKS, Klingenberg O, Fjeld B, Iversen PO, Brodwall KM, Bechensteen AG (2023)
    [Sickle cell disease – clinical manifestations and diagnostics]
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.22.0353, PubMed 36811424
96. Vo CD, Myhre AE, Abrahamsen IW, Remberger M, Mattsson J, Fløisand Y, Grønvold BCL, Tjønnfjord GE, Tvedt THA, Gedde-Dahl T (2023)
    Allogeneic stem cell transplantation in adults 2015-21
    Tidsskr Nor Laegeforen, 143 (4)
    DOI 10.4045/tidsskr.22.0521, PubMed 36919291
97. Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
    von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
    Res Pract Thromb Haemost, 7 (4), 100164
    DOI 10.1016/j.rpth.2023.100164, PubMed 37255854
98. Westhrin M, Blazevski J, Textor A, Abdollahi P, Gopalakrishnan RP, Ngo LT, Hofgaard PO, Heinzelbecker J, Bobic S, Fossum E, Spång HCL, Braathen R, Bogen B (2023)
    Id-neoantigen vaccine induces therapeutic CD8⁺ T cells against multiple myeloma: H chain-loss escapees cause FLC MM
    J Immunother Cancer, 11 (8)
    DOI 10.1136/jitc-2023-006944, PubMed 37607769
99. Ågnes C, Schwartz T, Quist-Paulsen E, Bhatti R, Njaastad AM, Fuglestved J, Wibetoe G (2023)
    Drug-induced aseptic meningitis
    Tidsskr Nor Laegeforen, 143 (1)
    DOI 10.4045/tidsskr.22.0286, PubMed 36655954

Publications 2022

1. Albert MH, Sirait T, Eikema DJ, Bakunina K, Wehr C, Suarez F, Fox ML, Mahlaoui N, Gennery AR, Lankester AC, Beier R, Bernardo ME, Bigley V, Lindemans CA, Burns SO, Carpenter B, Dybko J, Güngör T, Hauck F, Lum SH, Balashov D, Meisel R, Moshous D, Schulz A, Speckmann C et al. (2022)
   Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study
   Blood, 140 (14), 1635-1649
   DOI 10.1182/blood.2022015506, PubMed 35344580
2. Arvanitakis A, Holme PA, Berntorp E, Astermark J (2022)
   Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81-8973
   Haemophilia, 28 (2), 223-229
   DOI 10.1111/hae.14489, PubMed 35005818
3. Berentsen S, Tjønnfjord GE (2022)
   Current Treatment Options in Cold Agglutinin Disease: B-Cell Directed or Complement Directed Therapy?
   Transfus Med Rev, 36 (4), 181-187
   DOI 10.1016/j.tmrv.2022.05.001, PubMed 36127205
4. Berge-Seidl S, Nielsen NV, Rodriguez Alfonso AA, Etscheid M, Kandanur SPS, Haug BE, Stensland M, Thiede B, Karacan M, Preising N, Wiese S, Ständker L, Declerck PJ, Løset GÅ, Kanse SM (2022)
   Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation
   ACS Chem Biol, 17 (9), 2631-2642
   DOI 10.1021/acschembio.2c00538, PubMed 36070465
5. Bistervels IM, Bavalia R, Beyer-Westendorf J, Ten Cate-Hoek AJ, Schellong SM, Kovacs MJ, Falvo N, Meijer K, Stephan D, Boersma WG, Ten Wolde M, Couturaud F, Verhamme P, Brisot D, Kahn SR, Ghanima W, Montaclair K, Hugman A, Carroll P, Pernod G, Sanchez O, Ferrari E, Roy PM, Sevestre-Pietri MA, Birocchi S et al. (2022)
   Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
   Res Pract Thromb Haemost, 6 (5), e12748
   DOI 10.1002/rth2.12748, PubMed 35992565
6. Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S, Highlow Block writing committee, Highlow Investigators (2022)
   Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
   Lancet, 400 (10365), 1777-1787
   DOI 10.1016/S0140-6736(22)02128-6, PubMed 36354038
7. Cui XY, Stavik B, Thiede B, Sandset PM, Kanse SM (2022)
   FSAP Protects against Histone-Mediated Increase in Endothelial Permeability In Vitro
   Int J Mol Sci, 23 (22)
   DOI 10.3390/ijms232213706, PubMed 36430180
8. de la Morena-Barrio ME, Suchon P, Jacobsen EM, Iversen N, Miñano A, de la Morena-Barrio B, Bravo-Pérez C, Padilla J, Cifuentes R, Asenjo S, Deleuze JF, Trégouët DA, Lozano ML, Vicente V, Sandset PM, Morange PE, Corral J (2022)
   Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays
   Blood, 140 (2), 140-151
   DOI 10.1182/blood.2021014708, PubMed 35486842
9. Delluc A, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Rodger MA (2022)
   Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)
   Thromb Res, 213, 119-124
   DOI 10.1016/j.thromres.2022.03.014, PubMed 35344784
10. Diep PP, Rueegg CS, Burman MM, Brinch L, Bø K, Fosså K, Landrø L, Loge JH, Lund MB, Massey RJ, Myrdal OH, Pathak M, Rimstad L, Tanem KE, Tjønnfjord GE, Aaløkken TM, Ruud E (2022)
    Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation
    J Adolesc Young Adult Oncol, 12 (1), 66-75
    DOI 10.1089/jayao.2021.0196, PubMed 35544321
11. Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, Hájek R, Schjesvold F, Cavo M, Goldschmidt H, Facon T, Einsele H, Boccadoro M, San-Miguel J, Sonneveld P, Mey U, EHA Guidelines Committee ESMO Guidelines Committee. Electronic address: guidelines@ehaweb.org (2022)
    Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]
    Ann Oncol, 33 (9), 988
    DOI 10.1016/j.annonc.2022.05.004, PubMed 35810138
12. Dimopoulos MA, Schjesvold F, Doronin V, Vinogradova O, Quach H, Leleu X, Montes YG, Ramasamy K, Pompa A, Levin MD, Lee C, Mellqvist UH, Fenk R, Demarquette H, Sati H, Vorog A, Labotka R, Du J, Darif M, Kumar S (2022)
    Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial
    Blood Cancer J, 12 (1), 9
    DOI 10.1038/s41408-021-00593-2, PubMed 35075109
13. Enden T (2022)
    [Not Available]
    Tidsskr Nor Laegeforen, 142
    DOI 10.4045/tidsskr.22.0656, PubMed 36303471
14. Engh MS, Muhoozi GKM, Ngari M, Skaare AB, Westerberg AC, Iversen PO, Brusevold IJ, Atukunda P (2022)
    Long-Term Effects of a Randomized Maternal Education Trial in Rural Uganda: Implications for Child Oral Health
    Am J Trop Med Hyg, 107 (4), 939-947
    DOI 10.4269/ajtmh.22-0248, PubMed 36067985
15. Etscheid M, Hanschmann KM, Sandset PM, Kanse SM (2022)
    Development of a Factor VII Activating Protease (FSAP) generation assay and its application in studying FSAP in venous thrombosis
    Thromb Res, 220, 24-34
    DOI 10.1016/j.thromres.2022.09.027, PubMed 36265411
16. Garabet L, Eriksson A, Tjønnfjord E, Cui XY, Olsen MK, Jacobsen HK, Jørgensen CT, Mathisen ÅB, Mowinckel MC, Ahlen MT, Sørvoll IH, Horvei KD, Ernstsen SL, Lægreid IJ, Stavik B, Holst R, Sandset PM, Ghanima W (2022)
    SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people
    Res Pract Thromb Haemost, 7 (1), 100002
    DOI 10.1016/j.rpth.2022.100002, PubMed 36448024
17. Garcia-Horton A, Cyriac SL, Gedde-Dahl T, Floisand Y, Remberger M, Mattsson J, Michelis FV (2022)
    Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups
    Eur J Haematol, 109 (6), 672-679
    DOI 10.1111/ejh.13850, PubMed 36028979
18. Giliberto M, Thimiri Govinda Raj DB, Cremaschi A, Skånland SS, Gade A, Tjønnfjord GE, Schjesvold F, Munthe LA, Taskén K (2022)
    Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically
    Mol Oncol, 16 (6), 1241-1258
    DOI 10.1002/1878-0261.13191, PubMed 35148457
19. Gleditsch J, Jervan Ø, Haukeland-Parker S, Tavoly M, Geier O, Holst R, Klok FA, Johannessen HH, Ghanima W, Hopp E (2022)
    Effects of pulmonary rehabilitation on cardiac magnetic resonance parameters in patients with persistent dyspnea following pulmonary embolism
    Int J Cardiol Heart Vasc, 40, 100995
    DOI 10.1016/j.ijcha.2022.100995, PubMed 35345773
20. Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B, NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators (2022)
    CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19
    J Infect, 85 (6), 702-769
    DOI 10.1016/j.jinf.2022.09.029, PubMed 36216188
21. Grob T, Sanders MA, Vonk CM, Kavelaars FG, Rijken M, Hanekamp DW, Gradowska PL, Cloos J, Fløisand Y, van Marwijk Kooy M, Manz MG, Ossenkoppele GJ, Tick LW, Havelange V, Löwenberg B, Jongen-Lavrencic M, Valk PJM (2022)
    Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia
    J Clin Oncol, 41 (4), 756-765
    DOI 10.1200/JCO.22.00715, PubMed 36315929
22. Gundesen MT, Asmussen JT, Haukås E, Schubert M, Abildgaard N, Schjesvold F, Lund T (2022)
    A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma
    Eur J Haematol, 108 (5), 423-429
    DOI 10.1111/ejh.13749, PubMed 35113466
23. Haroun-Izquierdo A, Vincenti M, Netskar H, van Ooijen H, Zhang B, Bendzick L, Kanaya M, Momayyezi P, Li S, Wiiger MT, Hoel HJ, Krokeide SZ, Kremer V, Tjonnfjord G, Berggren S, Wikström K, Blomberg P, Alici E, Felices M, Önfelt B, Höglund P, Valamehr B, Ljunggren HG, Björklund A, Hammer Q et al. (2022)
    Adaptive single-KIR⁺NKG2C⁺ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
    J Immunother Cancer, 10 (11)
    DOI 10.1136/jitc-2022-005577, PubMed 36319065
24. Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
    Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    J Transl Med, 20 (1), 225
    DOI 10.1186/s12967-022-03432-5, PubMed 35568909
25. Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
    Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
    J Transl Med, 20 (1), 317
    DOI 10.1186/s12967-022-03518-0, PubMed 35841045
26. Hetland G, Fagerhol MK, Wiedmann MKH, Søraas AVL, Mirlashari MR, Nissen-Meyer LSH, Istre MS, Holme PA, Schultz NH (2022)
    Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects
    Vaccines (Basel), 10 (8)
    DOI 10.3390/vaccines10081267, PubMed 36016155
27. Hjertholm KG, Holmboe-Ottesen G, Mdala I, Shi Z, Iversen PO (2022)
    The impact of dietary diversity and seasonality in food availability on the quantile distribution of birth size among pregnant women in rural Malawi - a cross-sectional study
    BMC Pregnancy Childbirth, 22 (1), 602
    DOI 10.1186/s12884-022-04924-4, PubMed 35897009
28. Horn MA, Myhre AE, Prescott T, Aasly J, Sundal CH, Gedde-Dahl T (2022)
    Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy
    Mov Disord, 37 (5), 1108-1109
    DOI 10.1002/mds.29011, PubMed 35587623
29. Huuhtanen J, Ilander M, Yadav B, Dufva OM, Lähteenmäki H, Kasanen T, Klievink J, Olsson-Strömberg U, Stentoft J, Richter J, Koskenvesa P, Höglund M, Söderlund S, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Stenke L, Myhr-Eriksson K, Markevärn B, Lübking A, Dimitrijevic A, Udby L, Bjerrum OW, Hjorth-Hansen H et al. (2022)
    IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
    J Clin Invest, 132 (17)
    DOI 10.1172/JCI152585, PubMed 36047494
30. Imbery JF, Heinzelbecker J, Jebsen JK, McGowan M, Myklebust C, Bottini N, Stanford SM, Skånland SS, Tveita A, Tjønnfjord GE, Munthe LA, Szodoray P, Nakken B (2022)
    T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation
    Br J Haematol, 198 (3), 556-573
    DOI 10.1111/bjh.18285, PubMed 35655388
31. Iversen PO, Hankin A, Horn J, Pedersen TH, Borgersen R, Frøen HM (2022)
    Deep Compartment Syndrome Without Myonecrosis: A Case Report on a Rare Complication of Sickle Cell Disease
    Cureus, 14 (9), e29164
    DOI 10.7759/cureus.29164, PubMed 36258983
32. Janssens R, Lang T, Vallejo A, Galinsky J, Morgan K, Plate A, De Ronne C, Verschueren M, Schoefs E, Vanhellemont A, Delforge M, Schjesvold F, Cabezudo E, Vandebroek M, Stevens H, Simoens S, Huys I (2022)
    What matters most to patients with multiple myeloma? A Pan-European patient preference study
    Front Oncol, 12, 1027353
    DOI 10.3389/fonc.2022.1027353, PubMed 36523996
33. Jønsson V, Awan H, Jones ND, Johannesen TB, Thøgersen K, Steig BÁ, Andorsdottir G, Tjønnfjord GE (2022)
    Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders
    Sci Rep, 12 (1), 6138
    DOI 10.1038/s41598-022-09602-1, PubMed 35413962
34. Jørgensen CT, Tavoly M, Pettersen HH, Førsund E, Roaldsnes C, Olsen MK, Tjønnfjord E, Gleditsch J, Galovic AG, Vikum SF, Brækkan SK, Ghanima W (2022)
    The venous thrombosis registry in Østfold Hospital (TROLL registry) - design and cohort description
    Res Pract Thromb Haemost, 6 (5)
    DOI 10.1002/rth2.12770, PubMed 35949883
35. Katenga-Kaunda LZ, Iversen PO, Kamudoni PR, Holmboe-Ottesen G, Fjeld HE (2022)
    Food-based nutrition counselling and education intervention for improved diets of pregnant women in rural Malawi: a qualitative study of factors influencing dietary behaviour change
    Public Health Nutr, 25 (9), 2436-2447
    DOI 10.1017/S1368980022000593, PubMed 35369896
36. Kihlberg K, Baghaei F, Bruzelius M, Funding E, Holme PA, Lassila R, Martin M, Nummi V, Ranta S, Strandberg K, Andersson NG, Berntorp E, Astermark J (2022)
    Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
    Thromb Res, 217, 22-32
    DOI 10.1016/j.thromres.2022.06.015, PubMed 35842956
37. Klamroth R, Ay C, De Moerloose P, Fontana P, Windyga J, Astermark J, Berntorp E, Carvalho M, Dolan G, Hermans C, Holme PA, Kenet G, Mancuso ME, Marquardt N, Nunez R, Pabinger I, Rodgers R, Valk PV, Yuste VJ, Zupan IP (2022)
    Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working Group
    Haemophilia, 29 (1), 21-32
    DOI 10.1111/hae.14674, PubMed 36271497
38. Klintman J, Akesson KE, Holme PA, Fischer K (2022)
    Bone mineral density in haemophilia - a multicentre study evaluating the impact of different replacement regimens
    Haemophilia, 28 (2), 239-246
    DOI 10.1111/hae.14487, PubMed 34994489
39. Koroma AS, Ellie M, Bangura K, Iversen PO, Hendrixson DT, Stephenson K, Manary MJ (2022)
    Supplementary feeding and infection control in pregnant adolescents-A secondary analysis of a randomized trial among malnourished women in Sierra Leone
    Matern Child Nutr, 19 (1), e13456
    DOI 10.1111/mcn.13456, PubMed 36349973
40. Krausz M, Uhlmann A, Rump IC, Ihorst G, Goldacker S, Sogkas G, Posadas-Cantera S, Schmidt R, Feißt M, Alsina L, Dybedal I, Recher M, Warnatz K, Grimbacher B (2022)
    The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial
    Contemp Clin Trials Commun, 30, 101008
    DOI 10.1016/j.conctc.2022.101008, PubMed 36262801
41. Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA (2022)
    Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
    J Thromb Haemost, 20 (5), 1166-1181
    DOI 10.1111/jth.15666, PubMed 35114046
42. Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2022)
    "Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
    J Thromb Haemost, 20 (8), 1937-1939
    DOI 10.1111/jth.15774, PubMed 35859282
43. Larsen TL, Ghanima W, Sandset PM, Frøen H, Jacobsen EM, Torfoss D, Dahm AEA (2022)
    [Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients]
    Tidsskr Nor Laegeforen, 142 (1)
    DOI 10.4045/tidsskr.22.0228, PubMed 36655971
44. Lehtinen AE, Baghaei F, Astermark J, Holme PA (2022)
    Surgical outcomes in patients with haemophilia A or B receiving extended half-life recombinant factor VIII and IX Fc fusion proteins: Real-world experience in the Nordic countries
    Haemophilia, 28 (5), 713-719
    DOI 10.1111/hae.14585, PubMed 35575446
45. Leleu X, Martin T, Weisel K, Schjesvold F, Iida S, Malavasi F, Manier S, Chang-Ki Min, Ocio EM, Pawlyn C, Perrot A, Quach H, Richter J, Spicka I, Yong K, Richardson PG (2022)
    Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
    Ann Hematol, 101 (10), 2123-2137
    DOI 10.1007/s00277-022-04917-5, PubMed 35943588
46. Lindahl JP, Barlinn R, Abrahamsen IW, Spetalen S, Midtvedt K, Jenssen T (2022)
    Case Report: Pure Red Cell Aplasia Caused by Refractory Parvovirus B19 Infection After Pancreas Transplantation Alone
    Front Med (Lausanne), 9, 849783
    DOI 10.3389/fmed.2022.849783, PubMed 35372384
47. Massey RJ, Myrdal OH, Diep PP, Burman MM, Brinch L, Gullestad LL, Ruud E, Aakhus S, Beitnes JO (2022)
    Reduced exercise capacity is associated with left ventricular systolic dysfunction in long-term survivors of allogeneic hematopoietic stem-cell transplantation
    J Clin Ultrasound, 51 (1), 5-15
    DOI 10.1002/jcu.23264, PubMed 35788941
48. Matlary RED, Grinda N, Sayers F, Versloot O, McLaughlin P, EAHAD Physiotherapists Committee (2022)
    Promoting physical activity for people with haemophilia in the age of new treatments
    Haemophilia, 28 (6), 885-890
    DOI 10.1111/hae.14641, PubMed 35896000
49. Matlary RED, Holme PA, Glosli H, Rueegg CS, Grydeland M (2022)
    Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia
    Haemophilia, 28 (6), e172-e180
    DOI 10.1111/hae.14624, PubMed 35830613
50. McPherson S, Mitchell AK, Sletten I, Kvande ME, Steindal SA (2022)
    Haematological nurses' experiences about palliative care trajectories of patients with life-threatening haematological malignancies: A qualitative study
    Nurs Open, 10 (5), 3094-3103
    DOI 10.1002/nop2.1558, PubMed 36539384
51. Midtvedt Ø, Stray-Pedersen A, Andersson H, Gunnarsson R, Tveten K, Ali MM, Tjønnfjord GE (2022)
    A man in his sixties with chondritis and bone marrow failure
    Tidsskr Nor Laegeforen, 142 (4)
    DOI 10.4045/tidsskr.21.0370, PubMed 35239266
52. Molteberg E, Taubøll E, Kverneland M, Iversen PO, Selmer KK, Nakken KO, Hofoss D, Thorsby PM (2022)
    Substantial early changes in bone and calcium metabolism among adult pharmacoresistant epilepsy patients on a modified Atkins diet
    Epilepsia, 63 (4), 880-891
    DOI 10.1111/epi.17169, PubMed 35092022
53. Muhoozi GKM, Li K, Atukunda P, Skaare AB, Willumsen T, Enersen M, Westerberg AC, Morris A, Vieira AR, Iversen PO, Methé BA (2022)
    Child saliva microbiota and caries: a randomized controlled maternal education trial in rural Uganda
    Sci Rep, 12 (1), 7857
    DOI 10.1038/s41598-022-11979-y, PubMed 35552492
54. Nagler A, Galimard JE, Labopin M, Blaise D, Arcese W, Trisolini SM, Wu D, Pigneux A, Van Gorkom G, Rubio MT, Gedde-Dahl T, Huynh A, Lanza F, Gorin NC, Mohty M (2022)
    Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT
    Cancer Med, 12 (2), 1482-1491
    DOI 10.1002/cam4.5039, PubMed 35891608
55. Nagler A, Labopin M, Craddock C, Socié G, Yakoub-Agha I, Gedde-Dahl T, Niittyvuopio R, Byrne JL, Cornelissen JJ, Labussière-Wallet H, Arcese W, Milpied N, Esteve J, Canaani J, Mohty M (2022)
    Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation
    Am J Hematol, 97 (3), 274-282
    DOI 10.1002/ajh.26442, PubMed 34978724
56. Nagler A, Ngoya M, Galimard JE, Labopin M, Kröger N, Socié G, Gedde-Dahl T, Potter V, Schroeder T, Platzbecker U, Ganser A, Blaise D, Salmenniemi U, Maertens J, Craddock C, Labussière-Wallet H, Yakoub-Agha I, Savani B, Mohty M (2022)
    Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
    Bone Marrow Transplant, 57 (12), 1788-1796
    DOI 10.1038/s41409-022-01825-0, PubMed 36114249
57. Nagler A, Ngoya M, Galimard JE, Labopin M, Kröger N, Socié G, Gedde-Dahl T, Potter V, Schroeder T, Platzbecker U, Ganser A, Blaise D, Salmenniemi U, Maertens J, Craddock C, Labussière-Wallet H, Yakoub-Agha I, Savani B, Mohty M (2022)
    Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
    Bone Marrow Transplant, 57 (12), 1856
    DOI 10.1038/s41409-022-01853-w, PubMed 36280759
58. Nahalomo A, Iversen PO, Andreassen BA, Kaaya AN, Rukooko AB, Rukundo PM (2022)
    Seasonality- and disaster effects on food variety and food insecurity coping strategies among a landslide-prone cohort
    Clin Nutr ESPEN, 52, 229-239
    DOI 10.1016/j.clnesp.2022.11.005, PubMed 36513458
59. Nahalomo A, Iversen PO, Andreassen BA, Kaaya AN, Rukooko AB, Tushabe G, Nateme NC, Rukundo PM (2022)
    Malnutrition and Associated Risk Factors among Children 6-59 Months Old in the Landslide-Prone Bududa District, Eastern Uganda: A Cohort Study
    Curr Dev Nutr, 6 (2), nzac005
    DOI 10.1093/cdn/nzac005, PubMed 35198847
60. Ng S, Rodger MA, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, Kearon C, Mallick R, Delluc A (2022)
    External Validation of the Patient-Reported Villalta Scale for the Diagnosis of Postthrombotic Syndrome
    Thromb Haemost, 122 (8), 1379-1383
    DOI 10.1055/a-1738-1313, PubMed 35021257
61. Ocio EM, Nadeem O, Schjesvold F, Gay F, Touzeau C, Dimopoulos MA, Richardson PG, Mateos MV (2022)
    Melflufen for the treatment of multiple myeloma
    Expert Rev Clin Pharmacol, 15 (4), 371-382
    DOI 10.1080/17512433.2022.2075847, PubMed 35723075
62. Pedersen S, Kverneland M, Nakken KO, Rudi K, Iversen PO, Gervin K, Selmer KK (2022)
    Genome-wide decrease in DNA methylation in adults with epilepsy treated with modified ketogenic diet: A prospective study
    Epilepsia, 63 (9), 2413-2426
    DOI 10.1111/epi.17351, PubMed 35762681
63. Rasmussen B, Göhring G, Bernard E, Nilsson L, Tobiasson M, Jädersten M, Garelius H, Dybedal I, Grønbaek K, Ejerblad E, Lorenz F, Flogegård M, Marcher CW, Öster Fernström A, Cavelier L, Papaemmanuil E, Ebeling F, Kittang AO, Nørgaard JM, Saft L, Möllgård L, Hellström-Lindberg E (2022)
    "Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)"
    Leukemia, 36 (5), 1436-1439
    DOI 10.1038/s41375-022-01537-w, PubMed 35277655
64. Reiter A, Schwaab J, DeAngelo DJ, Gotlib J, Deininger MW, Pettit KM, Alvarez-Twose I, Vannucchi AM, Panse J, Platzbecker U, Hermine O, Dybedal I, Lin HM, Rylova SN, Ehlert K, Dimitrijević S, Radia DH (2022)
    Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
    Blood Adv, 6 (21), 5750-5762
    DOI 10.1182/bloodadvances.2022007539, PubMed 35640224
65. Rempelos L, Wang J, Barański M, Watson A, Volakakis N, Hadall C, Hasanaliyeva G, Chatzidimitriou E, Magistrali A, Davis H, Vigar V, Średnicka-Tober D, Rushton S, Rosnes KS, Iversen PO, Seal CJ, Leifert C (2022)
    Diet, but not food type, significantly affects micronutrient and toxic metal profiles in urine and/or plasma; a randomized, controlled intervention trial
    Am J Clin Nutr, 116 (5), 1278-1290
    DOI 10.1093/ajcn/nqac233, PubMed 36041176
66. Rempelos L, Wang J, Barański M, Watson A, Volakakis N, Hoppe HW, Kühn-Velten WN, Hadall C, Hasanaliyeva G, Chatzidimitriou E, Magistrali A, Davis H, Vigar V, Średnicka-Tober D, Rushton S, Iversen PO, Seal CJ, Leifert C (2022)
    Diet and food type affect urinary pesticide residue excretion profiles in healthy individuals: results of a randomized controlled dietary intervention trial
    Am J Clin Nutr, 115 (2), 364-377
    DOI 10.1093/ajcn/nqab308, PubMed 34718382
67. Richardson PG, Perrot A, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Malinge L, Dubin F, van de Velde H, Anderson KC (2022)
    Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
    Lancet Oncol, 23 (3), 416-427
    DOI 10.1016/S1470-2045(22)00019-5, PubMed 35151415
68. Richartz N, Pietka W, Gilljam KM, Skah S, Skålhegg BS, Bhagwat S, Naderi EH, Ruud E, Blomhoff HK (2022)
    cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
    Mol Cancer Res, 20 (3), 400-411
    DOI 10.1158/1541-7786.MCR-21-0652, PubMed 34880123
69. Røed-Undlien H, Schultz NH, Lunnan A, Husebråten IM, Wollmann BM, Molden E, Bjørnstad JL (2022)
    In Vitro Apixaban Removal By CytoSorb Whole Blood Adsorber: An Experimental Study
    J Cardiothorac Vasc Anesth, 36 (6), 1636-1644
    DOI 10.1053/j.jvca.2022.01.038, PubMed 35272914
70. Schjesvold F, Paiva B, Ribrag V, Rodriguez-Otero P, San-Miguel JF, Robak P, Hansson M, Onishi M, Hamidi H, Malhi V, Dail M, Javery A, Ku G, Raab MS (2022)
    Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma
    Clin Lymphoma Myeloma Leuk, 23 (1), e59-e70
    DOI 10.1016/j.clml.2022.10.006, PubMed 36450626
71. Schjesvold F, Richardson PG, Facon T, Alegre A, Spencer A, Jurczyszyn A, Sunami K, Frenzel L, Min CK, Guillonneau S, Lin PL, Le-Guennec S, Campana F, Van de Velde H, Bensfia S, Bringhen S (2022)
    Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis
    Haematologica, 107 (3), 774-775
    DOI 10.3324/haematol.2021.279160, PubMed 35229573
72. Schjesvold FH, Bakker NA, Sonneveld P (2022)
    Melflufen in multiple myeloma: the conclusion matters - Authors' reply
    Lancet Haematol, 9 (4), e244-e245
    DOI 10.1016/S2352-3026(22)00071-0, PubMed 35358436
73. Schjesvold FH, Bakker NA, Sonneveld P (2022)
    Authors' reply: Perspective: The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA
    Transl Oncol, 25, 101528
    DOI 10.1016/j.tranon.2022.101528, PubMed 36087383
74. Schjesvold FH, Dimopoulos MA, Delimpasi S, Robak P, Coriu D, Legiec W, Pour L, Špička I, Masszi T, Doronin V, Minarik J, Salogub G, Alekseeva Y, Lazzaro A, Maisnar V, Mikala G, Rosiñol L, Liberati AM, Symeonidis A, Moody V, Thuresson M, Byrne C, Harmenberg J, Bakker NA, Hájek R et al. (2022)
    Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study
    Lancet Haematol, 9 (2), e98-e110
    DOI 10.1016/S2352-3026(21)00381-1, PubMed 35032434
75. Schmitz A, Brøndum RF, Johnsen HE, Mellqvist UH, Waage A, Gimsing P, Op Bruinink DH, van der Velden V, van der Holt B, Hansson M, Andersen NF, Frølund UC, Helleberg C, Schjesvold FH, Ahlberg L, Gulbrandsen N, Andreasson B, Lauri B, Haukas E, Bødker JS, Roug AS, Bøgsted M, Severinsen MT, Gregersen H, Abildgaard N et al. (2022)
    Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
    BMC Cancer, 22 (1), 147
    DOI 10.1186/s12885-022-09184-1, PubMed 35123422
76. Schultz NH, Søraas AVL, Sørvoll IH, Akkök ÇA, Vetlesen A, Bhamra JS, Ahlen MT, Holme PA, Aamodt AH, Skagen K, Skattør TH, Skjelland M, Wiedmann MK (2022)
    Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
    J Stroke Cerebrovasc Dis, 32 (1), 106860
    DOI 10.1016/j.jstrokecerebrovasdis.2022.106860, PubMed 36403363
77. Skånland SS, Inngjerdingen M, Bendiksen H, York J, Spetalen S, Munthe LA, Tjønnfjord GE (2022)
    Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case
    Haematologica, 107 (8), 1994-1998
    DOI 10.3324/haematol.2021.280393, PubMed 35236056
78. Skånland SS, Tjønnfjord GE (2022)
    Determining drug dose in the era of targeted therapies: playing it (un)safe?
    Blood Cancer J, 12 (8), 123
    DOI 10.1038/s41408-022-00720-7, PubMed 35999205
79. Solhaug TS, Tjønnfjord GE, Bjørgo K, Kildahl-Andersen O (2022)
    A family with cytotoxic T-lymphocyte-associated protein 4 haploinsufficiency presenting with aplastic anaemia
    BMJ Case Rep, 15 (2)
    DOI 10.1136/bcr-2021-247653, PubMed 35228238
80. Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, Nuruddin S, Connelly J, Schjesvold F, Revheim ME (2022)
    Comparison of [¹⁸F]fluciclovine and [¹⁸F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
    Mol Imaging Biol, 24 (5), 842-851
    DOI 10.1007/s11307-022-01734-0, PubMed 35501622
81. Strømmen K, Lyche JL, Moltu SJ, Müller MHB, Blakstad EW, Brække K, Sakhi AK, Thomsen C, Nakstad B, Rønnestad AE, Drevon CA, Iversen PO (2022)
    Estimated daily intake of phthalates, parabens, and bisphenol A in hospitalised very low birth weight infants
    Chemosphere, 309 (Pt 1), 136687
    DOI 10.1016/j.chemosphere.2022.136687, PubMed 36206919
82. Swan D, Hayden PJ, Eikema DJ, Koster L, Sauer S, Blaise D, Nicholson E, Rabin N, Touzeau C, Byrne J, Huynh A, Cornelissen JJ, Potter V, Forcade E, Parrish C, Gribben J, Chretien ML, Mielke S, Gedde-Dahl T, Reményi P, Tsirigotis P, Garcia Guiñón A, Beksac M, Schönland S, Yakoub-Agha I (2022)
    Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
    Br J Haematol, 197 (1), 82-96
    DOI 10.1111/bjh.18025, PubMed 35166376
83. Szanto T, Zetterberg E, Ramström S, Leinøe EB, Holme PA, Antovic JP, Holmström M, Onundarson PT, Pikta M, Vaide I, Olsson A, Magnusson M, Kärkkäinen S, Bitar M, Poulsen LH, Lassila R, Nordic Haemophilia Council (2022)
    Platelet function testing: Current practice among clinical centres in Northern Europe
    Haemophilia, 28 (4), 642-648
    DOI 10.1111/hae.14578, PubMed 35510959
84. Tanem KE, Wilberg P, Diep PP, Ruud E, Skaare AB, Brinch L, Herlofson BB (2022)
    Oral chronic GVHD after allogeneic stem cell transplantation without total body irradiation performed at a young age
    Support Care Cancer, 30 (5), 4121-4128
    DOI 10.1007/s00520-022-06836-7, PubMed 35075489
85. Tarasco E, von Krogh AS, Hrdlickova R, Braschler TR, Iwaniec T, Knöbl PN, Hamada E, Pikovsky O, Farese S, Gutwein O, Kessler P, Schultz NH, von Auer C, Windyga J, Friedman K, Hrachovinova I, George JN, Matsumoto M, Schneppenheim R, Lämmle B, Kremer Hovinga JA (2022)
    Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease
    Res Pract Thromb Haemost, 6 (7), e12814
    DOI 10.1002/rth2.12814, PubMed 36284639
86. Tavoly M, Asady E, Wik HS, Ghanima W (2022)
    Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?
    Semin Thromb Hemost, 49 (8), 861-866
    DOI 10.1055/s-0042-1754390, PubMed 36055276
87. Tholin B, Fiskvik H, Tveita A, Tsykonova G, Opperud H, Busterud K, Mpinganzima C, Garabet L, Ahmed J, Stavem K, Ghanima W (2022)
    Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis
    Thromb Update, 6, 100096
    DOI 10.1016/j.tru.2021.100096, PubMed 38620916
88. Toksvang LN, Als-Nielsen B, Bacon C, Bertasiute R, Duarte X, Escherich G, Helgadottir EA, Johannsdottir IR, Jónsson ÓG, Kozlowski P, Langenskjöld C, Lepik K, Niinimäki R, Overgaard UM, Punab M, Räty R, Segers H, van der Sluis I, Smith OP, Strullu M, Vaitkevičienė G, Wik HS, Heyman M, Schmiegelow K (2022)
    Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol
    BMC Cancer, 22 (1), 483
    DOI 10.1186/s12885-022-09522-3, PubMed 35501736
89. Trøseid M, Dahl TB, Holter JC, Kildal AB, Murphy SL, Yang K, Quiles-Jiménez A, Heggelund L, Müller KE, Tveita A, Michelsen AE, Bøe S, Holten AR, Hoel H, Mathiessen A, Aaløkken TM, Fevang B, Granerud BK, Tonby K, Henriksen KN, Lerum TV, Müller F, Skjønsberg OH, Barratt-Due A, Dyrhol-Riise AM et al. (2022)
    Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies
    J Intern Med, 292 (5), 816-828
    DOI 10.1111/joim.13549, PubMed 35982589
90. Tsykunova G, Ghanima W (2022)
    Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives
    Ther Clin Risk Manag, 18, 273-286
    DOI 10.2147/TCRM.S251672, PubMed 35386180
91. Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, Kaarbø M, Heggelund L, Holten AR, Finbråten AK, Müller KE, Mathiessen A, Bøe S, Fevang B, Granerud BK, Tonby K, Lind A, Dudman SG, Henriksen KN, Müller F, Skjønsberg OH, Trøseid M, Barratt-Due A, Dyrhol-Riise AM, Aukrust P et al. (2022)
    High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
    J Infect Dis, 226 (12), 2150-2160
    DOI 10.1093/infdis/jiac313, PubMed 35876699
92. Ueland T, Hausberg I, Mørtberg TV, Dahl TB, Lerum TV, Michelsen A, Ranheim T, Nezvalova Henriksen K, Dyrhol-Riise AM, Holme PA, Aaløkken TM, Skjønsberg OH, Barratt-Due A, Ahlén MT, Aukrust P, Halvorsen B (2022)
    Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology
    Platelets, 33 (4), 640-644
    DOI 10.1080/09537104.2022.2042238, PubMed 35225150
93. Vestad B, Ueland T, Lerum TV, Dahl TB, Holm K, Barratt-Due A, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Tonby K, Hoel H, Olsen IC, Henriksen KN, Tveita A, Manotheepan R, Haugli M, Eiken R, Berg Å, Halvorsen B, Lekva T, Ranheim T, Michelsen AE, Kildal AB, Johannessen A, Thoresen L et al. (2022)
    Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations
    J Intern Med, 291 (6), 801-812
    DOI 10.1111/joim.13458, PubMed 35212063
94. Warlo EMK, Bratseth V, Pettersen AR, Holme PA, Arnesen H, Seljeflot I, Opstad TB (2022)
    Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
    Clin Appl Thromb Hemost, 28, 10760296221141893
    DOI 10.1177/10760296221141893, PubMed 36474435
95. Wergeland D, Harsten K, Klarare A, Steindal SA (2022)
    Title authors reply to letter to Editor 'Follow-up care after stem-cell transplant'
    J Clin Nurs, 32 (13-14), 4195-4196
    DOI 10.1111/jocn.16436, PubMed 35818338
96. Yin Y, Athanasiadis P, Karlsen L, Urban A, Xu H, Murali I, Fernandes SM, Arribas AJ, Hilli AK, Taskén K, Bertoni F, Mato AR, Normant E, Brown JR, Tjønnfjord GE, Aittokallio T, Skånland SS (2022)
    Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia
    Clin Cancer Res, 28 (20), 4444-4455
    DOI 10.1158/1078-0432.CCR-22-1221, PubMed 35998013
97. Aasebo AT, Gedde-Dahl T, Reims HM, Baekkevold ES, Jahnsen FL (2022)
    Calprotectin Expressing Donor-Derived Macrophages Increase in Acute Gastrointestinal Graft-Versus-Host Disease
    Transplant Cell Ther, 28 (5), 248.e1-248.e8
    DOI 10.1016/j.jtct.2022.01.028, PubMed 35144036